| APOLLO.AP-2XNK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-3336 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-7GDN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-9UHJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy] |
| APOLLO.AP-AGZG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Lepidic adenocarcinoma] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-B9CH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy] |
| APOLLO.AP-D35H |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-DMUM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[] |
[Chemotherapy] |
| APOLLO.AP-DT88 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Chemotherapy] |
| APOLLO.AP-EPNF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-EZEX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-FX68 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Chemotherapy] |
| APOLLO.AP-HML4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-JKPX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-LWHD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-N8FG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-NMZS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-QAHT |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Mucinous adenocarcinoma] |
[male] |
[] |
[] |
[Chemotherapy] |
| APOLLO.AP-QUHC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-RQNH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-SJVE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-VLXG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| APOLLO.AP-W455 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-XSR5 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-YTZ8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Lepidic adenocarcinoma] |
[male] |
[Stage IA] |
[] |
[] |
| APOLLO.AP-ZLDH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-A8B0 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1937 |
2003 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-A8B6 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1929 |
2005 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-A8B7 |
<NA> |
Non-Hispanic |
White |
human |
1933 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-A8B9 |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABIW |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1962 |
2003 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABIX |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1942 |
2003 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABIZ |
<NA> |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJ3 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJ4 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1936 |
2004 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJ9 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1945 |
2002 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJH |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJI |
<NA> |
Non-Hispanic |
White |
human |
1931 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJO |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1950 |
2005 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABJP |
<NA> |
Non-Hispanic |
White |
human |
1933 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABK3 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1931 |
2006 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABK9 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABKE |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1942 |
2008 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABKI |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1944 |
2006 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABKU |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1925 |
2005 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABL4 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1958 |
2003 |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABL8 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
2006 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABLE |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABLL |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1936 |
2007 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABLQ |
<NA> |
Non-Hispanic |
White |
human |
1931 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ABM9 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1951 |
2004 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACIT |
<NA> |
Non-Hispanic |
White |
human |
1929 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACIV |
<NA> |
Non-Hispanic |
White |
human |
1938 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACJ1 |
<NA> |
Non-Hispanic |
White |
human |
1925 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACL2 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1941 |
2006 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACM9 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1927 |
2004 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACMK |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1934 |
2003 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACNN |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1935 |
2005 |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACPV |
<NA> |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACQ7 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1949 |
2009 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACQA |
<NA> |
Non-Hispanic |
White |
human |
1937 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACQQ |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1941 |
2006 |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACR2 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1923 |
2007 |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACR8 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
2002 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACRK |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1934 |
2004 |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CDDP_EAGLE.CDDP-ACRT |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-01-01250 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-01-01251 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-01-01252 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Lepidic adenocarcinoma] |
[male] |
[Stage III] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-01-01256 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-03-01004 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-03-01016 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-03-01018 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| CGCI.HTMCP-02-06-01037 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Lepidic adenocarcinoma] |
[male] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| CGCI.HTMCP-02-06-01050 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-06-01157 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-06-01158 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-06-01163 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-15-01098 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-02-25-01216 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, Low Dose, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02081 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, Low Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| CGCI.HTMCP-03-06-02085 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02139 |
Cancer-Related Death |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02150 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, Low Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02176 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| CGCI.HTMCP-03-06-02193 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02204 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02211 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02216 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02360 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02373 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02404 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02406 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02414 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| CGCI.HTMCP-03-06-02416 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02426 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02441 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CGCI.HTMCP-03-06-02448 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| CMI.PCProject_0013 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0022 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0028 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0031 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0035 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0036 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0041 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0048 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0054 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0056 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0057 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0062 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0085 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0087 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0093 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0100 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0120 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0123 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0125 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0130 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0136 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0142 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0149 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0161 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[inguinal lymph node] |
[] |
| CMI.PCProject_0177 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0181 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0182 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0186 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0187 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0190 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0193 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0212 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0213 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0215 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0225 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0234 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0254 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0256 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0319 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0336 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0357 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0364 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0381 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0392 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0399 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0410 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0439 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0443 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0445 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0488 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0495 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0501 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0524 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0525 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0557 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0575 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0588 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0608 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0639 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0643 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0653 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CMI.PCProject_0683 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[] |
| CPTAC.01BR043 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[breast] |
[] |
| CPTAC.01CO001 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.01CO005 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.01CO006 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.01CO008 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.01CO013 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.01CO014 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.01CO015 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.01CO019 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.01CO022 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.05CO002 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIA] |
[colon] |
[] |
| CPTAC.05CO003 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage II] |
[colon] |
[] |
| CPTAC.05CO005 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage I] |
[colon] |
[] |
| CPTAC.05CO006 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO007 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.05CO011 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO014 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO015 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO020 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO026 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO028 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.05CO029 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO032 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO033 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.05CO034 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO035 |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO037 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO039 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIB] |
[colon] |
[] |
| CPTAC.05CO041 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO044 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIB] |
[colon] |
[] |
| CPTAC.05CO045 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO047 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.05CO048 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.05CO049 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO050 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.05CO053 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.05CO054 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.05CO055 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.06CO001 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.06CO002 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.09CO005 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.09CO006 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.09CO008 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.09CO011 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.09CO013 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.09CO014 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.09CO015 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.09CO018 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIA] |
[colon] |
[] |
| CPTAC.09CO019 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.09CO022 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIB] |
[colon] |
[] |
| CPTAC.11BR050 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[] |
| CPTAC.11CO005 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO007 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO008 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO010 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO018 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO019 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO020 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO021 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.11CO022 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.11CO027 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO030 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO031 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO032 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO033 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO036 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO037 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO039 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO042 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO043 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO044 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.11CO045 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO047 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO048 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO051 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO052 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO053 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO054 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO057 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO058 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO059 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO060 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO061 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO062 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.11CO070 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO072 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11CO077 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.11CO079 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.11LU013 |
Cancer-Related Death |
<NA> |
Asian |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.11LU016 |
Cancer-Related Death |
<NA> |
Asian |
human |
1953 |
2016 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.11LU022 |
<NA> |
<NA> |
Asian |
human |
1962 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.11LU035 |
<NA> |
<NA> |
Asian |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.14CO002 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage II] |
[colon] |
[] |
| CPTAC.14CO003 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.14CO005 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.15CO001 |
<NA> |
Hispanic or Latino |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.15CO002 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIB] |
[colon] |
[] |
| CPTAC.16CO002 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.16CO003 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.16CO006 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.16CO011 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC.16CO012 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage I] |
[colon] |
[] |
| CPTAC.20BR008 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Neoplasm, malignant, Noninfiltrating intraductal papillary adenocarcinoma] |
[female] |
[Stage IIIB] |
[breast] |
[] |
| CPTAC.20CO001 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIA] |
[colon] |
[] |
| CPTAC.20CO003 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female, male] |
[Stage IVA] |
[colon] |
[] |
| CPTAC.20CO004 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.20CO007 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.21CO006 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage1, Stage I] |
[colon] |
[] |
| CPTAC.21CO007 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IV] |
[colon] |
[] |
| CPTAC.22CO004 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIA] |
[colon] |
[] |
| CPTAC.22CO006 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.24CO005 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage III] |
[colon] |
[] |
| CPTAC.27CO004 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| CPTAC.C223491 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[brain, frontal lobe, telencephalon] |
[] |
| CPTAC.C243909 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[brain, frontal lobe, telencephalon] |
[] |
| CPTAC.C266664 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[brain, telencephalon] |
[] |
| CPTAC.C3L-00001 |
<NA> |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-00004 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00006 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00008 |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00009 |
<NA> |
Non-Hispanic |
White |
human |
1939 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00010 |
<NA> |
Non-Hispanic |
White |
human |
1986 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00011 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1952 |
2016 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-00026 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00032 |
<NA> |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00079 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1967 |
2017 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-00080 |
<NA> |
Non-Hispanic |
White |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00083 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00086 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1959 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00088 |
Infection |
Non-Hispanic |
White |
human |
1943 |
2018 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00090 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1940 |
2019 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00093 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1949 |
2021 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00094 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1946 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00095 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00096 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
2016 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00097 |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00098 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-00103 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1960 |
2021 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00136 |
<NA> |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00137 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00139 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1932 |
2017 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00140 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00143 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00144 |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-00145 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00156 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00157 |
Cancer-Related Death |
Hispanic or Latino |
White |
human |
1956 |
2020 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00161 |
<NA> |
Hispanic or Latino |
White |
human |
1970 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00165 |
<NA> |
Hispanic or Latino |
White |
human |
1969 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3L-00183 |
<NA> |
Hispanic or Latino |
White |
human |
1982 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00263 |
<NA> |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3L-00279 |
<NA> |
<NA> |
White |
human |
1943 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00356 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
2020 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00358 |
<NA> |
Non-Hispanic |
White |
human |
1926 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00359 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
2021 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00360 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-00361 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00362 |
<NA> |
Non-Hispanic |
White |
human |
1978 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00368 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00369 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1926 |
2016 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00412 |
Cancer-Related Death |
Non-Hispanic |
American Indian or Alaska Native |
human |
1952 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00413 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00416 |
<NA> |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00418 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00422 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1981 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00444 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00446 |
Cardiovascular Disorder |
<NA> |
White |
human |
1944 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00447 |
<NA> |
Non-Hispanic |
White |
human |
1981 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00448 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00449 |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00510 |
<NA> |
<NA> |
<NA> |
human |
1936 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-00561 |
<NA> |
Non-Hispanic |
White |
human |
1966 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00563 |
<NA> |
Non-Hispanic |
Asian |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00581 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1964 |
2020 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-00583 |
<NA> |
Hispanic or Latino |
White |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00586 |
<NA> |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00601 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00604 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-00605 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00606 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1941 |
2019 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00607 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1950 |
2018 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00608 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Oxyphilic adenoma] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00610 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, liver, right kidney] |
[] |
| CPTAC.C3L-00765 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00766 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-00767 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00769 |
<NA> |
<NA> |
White |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00770 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, inguinal lymph node, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3L-00771 |
Cardiovascular Disorder |
Non-Hispanic |
White |
human |
1929 |
2016 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, chest, left lung, uterus] |
[] |
| CPTAC.C3L-00780 |
<NA> |
Hispanic or Latino |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, uterus] |
[] |
| CPTAC.C3L-00781 |
<NA> |
Hispanic or Latino |
White |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00789 |
<NA> |
<NA> |
White |
human |
1985 |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00790 |
<NA> |
<NA> |
White |
human |
1972 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00791 |
<NA> |
<NA> |
White |
human |
1940 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00792 |
<NA> |
<NA> |
White |
human |
1926 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[abdomen, blood, kidney, right adrenal gland, right kidney] |
[] |
| CPTAC.C3L-00796 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00799 |
<NA> |
Non-Hispanic |
White |
human |
1975 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, chest, kidney, left kidney, mediastinal lymph node] |
[] |
| CPTAC.C3L-00800 |
<NA> |
<NA> |
White |
human |
1975 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-00812 |
<NA> |
<NA> |
White |
human |
1942 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, chest, kidney, left kidney, paratracheal lymph node, right kidney] |
[] |
| CPTAC.C3L-00813 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-00814 |
<NA> |
<NA> |
<NA> |
human |
1933 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00815 |
<NA> |
<NA> |
White |
human |
1938 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-00817 |
<NA> |
<NA> |
White |
human |
1936 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-00893 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00898 |
<NA> |
Hispanic or Latino |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00902 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00905 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00907 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00908 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-00910 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00913 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1950 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3L-00917 |
<NA> |
Hispanic or Latino |
White |
human |
1978 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00918 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1947 |
2020 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00921 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00930 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[CDS, GDC, PDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00932 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00935 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage III] |
[blood, uterus] |
[] |
| CPTAC.C3L-00938 |
<NA> |
<NA> |
White |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00942 |
<NA> |
<NA> |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00943 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-00946 |
<NA> |
<NA> |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00947 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic lymph node, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3L-00949 |
<NA> |
<NA> |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-00961 |
Cardiovascular Disorder |
<NA> |
White |
human |
1957 |
2020 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, retroperitoneal lymph node, uterus] |
[] |
| CPTAC.C3L-00963 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-00966 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00968 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1955 |
2018 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3L-00969 |
<NA> |
<NA> |
<NA> |
human |
1976 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3L-00970 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3L-00973 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-00976 |
Cardiovascular Disorder |
<NA> |
<NA> |
human |
1949 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3L-00980 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00981 |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-00982 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-00991 |
<NA> |
<NA> |
<NA> |
human |
1971 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-01033 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3L-01034 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3L-01064 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdominopelvic cavity, blood, chest, trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01102 |
<NA> |
<NA> |
Asian |
human |
1970 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01106 |
Cancer-Related Death |
<NA> |
Asian |
human |
1966 |
2017 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[blood, kidney] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01107 |
<NA> |
<NA> |
Asian |
human |
1973 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01246 |
<NA> |
<NA> |
White |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01247 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, left pelvic girdle region, pelvic region of trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01248 |
<NA> |
<NA> |
White |
human |
1974 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01249 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01252 |
<NA> |
<NA> |
White |
human |
1940 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01253 |
<NA> |
<NA> |
White |
human |
1939 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01256 |
<NA> |
<NA> |
White |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01257 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01275 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01277 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[abdomen, blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01279 |
<NA> |
Non-Hispanic |
Asian |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01281 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-01282 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01283 |
<NA> |
Hispanic or Latino |
White |
human |
1980 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01286 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1958 |
2019 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01287 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1956 |
2018 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-01288 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01302 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
2017 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01304 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01307 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1942 |
2017 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-01311 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01312 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01313 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1953 |
2020 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01330 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-01352 |
<NA> |
Hispanic or Latino |
White |
human |
1940 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, left kidney, right kidney] |
[] |
| CPTAC.C3L-01355 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01459 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-01460 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01462 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, liver, right kidney] |
[] |
| CPTAC.C3L-01463 |
<NA> |
<NA> |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, chromophobe type] |
[female] |
[Stage I] |
[abdomen, blood, kidney] |
[] |
| CPTAC.C3L-01464 |
<NA> |
<NA> |
White |
human |
1938 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, abdominopelvic cavity, blood, kidney, left kidney, left renal vein] |
[Chemotherapy, Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-01465 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[abdomen, blood, chest, kidney, left kidney, mediastinal lymph node, right lung] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-01467 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Oxyphilic adenoma] |
[male] |
[Stage I] |
[abdomen, blood, kidney] |
[] |
| CPTAC.C3L-01470 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-01553 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01557 |
<NA> |
<NA> |
Black or African American |
human |
1966 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01560 |
<NA> |
<NA> |
White |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01599 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01603 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01607 |
<NA> |
Non-Hispanic |
White |
human |
1933 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01631 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1960 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01632 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1956 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-01633 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01639 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01664 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01665 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1949 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01668 |
<NA> |
Non-Hispanic |
White |
human |
1980 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-01672 |
<NA> |
Hispanic or Latino |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01676 |
<NA> |
Hispanic or Latino |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3L-01681 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
2021 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01682 |
<NA> |
Non-Hispanic |
White |
human |
1938 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-01683 |
Infection |
Non-Hispanic |
White |
human |
1939 |
2020 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-01729 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01732 |
<NA> |
<NA> |
White |
human |
1933 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01739 |
<NA> |
<NA> |
White |
human |
1946 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-01744 |
<NA> |
<NA> |
White |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, left pelvic girdle region, pelvic region of trunk, right pelvic girdle region, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01749 |
<NA> |
<NA> |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01833 |
<NA> |
<NA> |
White |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-01836 |
<NA> |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01840 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01861 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01862 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1935 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3L-01864 |
<NA> |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01869 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-01882 |
<NA> |
Non-Hispanic |
White |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01885 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01889 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-01890 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-01913 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC1] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-01924 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-01925 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[abdominopelvic cavity, blood, chest, pelvic region of trunk, trunk, uterus] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-01929 |
<NA> |
<NA> |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01951 |
<NA> |
<NA> |
White |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01952 |
<NA> |
<NA> |
White |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01954 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, left kidney, right adrenal gland, right kidney] |
[] |
| CPTAC.C3L-01958 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-01960 |
<NA> |
<NA> |
White |
human |
1936 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01962 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-01963 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3L-01967 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-01976 |
<NA> |
Hispanic or Latino |
White |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, abdominopelvic cavity, blood, kidney, right kidney] |
[] |
| CPTAC.C3L-01978 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, chest, kidney] |
[] |
| CPTAC.C3L-02119 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02121 |
<NA> |
Non-Hispanic |
White |
human |
1977 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02125 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02129 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[blood, lung] |
[] |
| CPTAC.C3L-02165 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3L-02169 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-02175 |
<NA> |
<NA> |
White |
human |
1968 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02176 |
<NA> |
<NA> |
White |
human |
1938 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02177 |
<NA> |
<NA> |
White |
human |
1965 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02201 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02202 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3L-02208 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02211 |
Non-Cancer Related Death |
<NA> |
Black or African American |
human |
1960 |
2018 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02214 |
<NA> |
<NA> |
White |
human |
1984 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02216 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC1] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02219 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1939 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-02220 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02345 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines)] |
| CPTAC.C3L-02346 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1947 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-02347 |
<NA> |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02348 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-02350 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-02352 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02353 |
<NA> |
Non-Hispanic |
White |
human |
1937 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02354 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02357 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02364 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02365 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1954 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02382 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
2022 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-02384 |
<NA> |
<NA> |
White |
human |
1935 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[] |
| CPTAC.C3L-02389 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-02392 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02399 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02403 |
<NA> |
<NA> |
White |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02408 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02409 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02411 |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02412 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02449 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02468 |
<NA> |
Hispanic or Latino |
White |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02508 |
<NA> |
Hispanic or Latino |
White |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-02513 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-02515 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02544 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1959 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02545 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02549 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1947 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-02551 |
<NA> |
Non-Hispanic |
White |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02553 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02555 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1946 |
2021 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02556 |
<NA> |
Non-Hispanic |
White |
human |
1931 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02557 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02559 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-02560 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-02601 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1946 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3L-02602 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02616 |
Cancer-Related Death |
<NA> |
White |
human |
1954 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3L-02643 |
Cancer-Related Death |
<NA> |
White |
human |
1950 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-02654 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3L-02661 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-02741 |
<NA> |
Non-Hispanic |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, uterus] |
[] |
| CPTAC.C3L-02744 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[abdomen, blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-02746 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-02747 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, chest, uterus] |
[] |
| CPTAC.C3L-02800 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC1] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02802 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[] |
| CPTAC.C3L-02834 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-02841 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, abdominal cavity, blood, chest, inferior vena cava, kidney, left kidney, lung, paraaortic lymph node] |
[] |
| CPTAC.C3L-02842 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02856 |
<NA> |
<NA> |
White |
human |
1928 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3L-02857 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3L-02893 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3L-02894 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1950 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02953 |
<NA> |
Hispanic or Latino |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3L-02954 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
1965 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02957 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-02958 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1943 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA1] |
[blood, lung] |
[] |
| CPTAC.C3L-02961 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA2] |
[blood, lung] |
[] |
| CPTAC.C3L-02967 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA2] |
[blood, lung] |
[] |
| CPTAC.C3L-02990 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-03143 |
<NA> |
Non-Hispanic |
Asian |
human |
1950 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-03262 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-03264 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-03268 |
<NA> |
Non-Hispanic |
White |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-03271 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-03462 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1956 |
2022 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-03463 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3L-03467 |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC] |
[abdomen, blood, chest, trunk, uterus] |
[Chemotherapy] |
| CPTAC.C3L-03589 |
<NA> |
Non-Hispanic |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, uterus] |
[] |
| CPTAC.C3L-03642 |
<NA> |
Non-Hispanic |
White |
human |
1954 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3L-03679 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-03717 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3L-03721 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-03726 |
<NA> |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female, male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3L-03969 |
Cancer-Related Death |
<NA> |
White |
human |
1941 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-03976 |
Cancer-Related Death |
<NA> |
White |
human |
1953 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Radiation Therapy, NOS] |
| CPTAC.C3L-03984 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-03985 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3L-04031 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-04033 |
<NA> |
<NA> |
White |
human |
1979 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3L-04037 |
Cancer-Related Death |
<NA> |
White |
human |
1966 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-04040 |
<NA> |
<NA> |
White |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3L-04365 |
<NA> |
<NA> |
White |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA1] |
[blood, lung] |
[] |
| CPTAC.C3L-04757 |
Cancer-Related Death |
<NA> |
White |
human |
1950 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3L-04759 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[blood, lung] |
[] |
| CPTAC.C3L-05571 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC1] |
[abdomen, abdominopelvic cavity, blood, chest, trunk, uterus] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3L-05848 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1948 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[abdomen, blood, uterus] |
[Chemotherapy] |
| CPTAC.C3L-05849 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC2] |
[abdomen, blood, chest, trunk, uterus] |
[Chemotherapy] |
| CPTAC.C3N-00148 |
<NA> |
<NA> |
White |
human |
1964 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00149 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3N-00150 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3N-00151 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-00154 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3N-00155 |
<NA> |
<NA> |
White |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-00167 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00168 |
<NA> |
<NA> |
Asian |
human |
1969 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00169 |
<NA> |
<NA> |
Asian |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00175 |
<NA> |
<NA> |
Asian |
human |
1944 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-00177 |
<NA> |
<NA> |
Asian |
human |
1964 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-00180 |
<NA> |
<NA> |
Asian |
human |
1960 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00194 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[abdomen, abdominopelvic cavity, blood, chest, kidney, left kidney, left renal vein] |
[Chemotherapy] |
| CPTAC.C3N-00199 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-00200 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
1944 |
2018 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[] |
| CPTAC.C3N-00203 |
<NA> |
<NA> |
<NA> |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-00217 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-00223 |
<NA> |
Non-Hispanic |
Asian |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-00242 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00243 |
<NA> |
Non-Hispanic |
White |
human |
1938 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3N-00244 |
<NA> |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, adrenal gland, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-00246 |
<NA> |
Non-Hispanic |
White |
human |
1972 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, abdominal lymph node, adrenal gland, blood, chest, kidney] |
[] |
| CPTAC.C3N-00293 |
<NA> |
<NA> |
White |
human |
1943 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-00294 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-00305 |
<NA> |
<NA> |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-00310 |
Infection |
<NA> |
White |
human |
1931 |
2020 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, chest, kidney, left adrenal gland, liver, mediastinal lymph node, right kidney] |
[] |
| CPTAC.C3N-00312 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, left adrenal gland, right kidney] |
[] |
| CPTAC.C3N-00313 |
<NA> |
<NA> |
White |
human |
1984 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-00314 |
Non-Cancer Related Death |
<NA> |
White |
human |
1937 |
2016 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-00315 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00317 |
<NA> |
<NA> |
White |
human |
1942 |
2020 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00320 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-00321 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00322 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00323 |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-00324 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00326 |
<NA> |
<NA> |
<NA> |
human |
1971 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-00328 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3N-00333 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00334 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00335 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00337 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00339 |
<NA> |
<NA> |
<NA> |
human |
1971 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00340 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3N-00377 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00379 |
<NA> |
<NA> |
<NA> |
human |
1974 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00380 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, craniocervical region, kidney, left kidney, thyroid gland, trunk] |
[] |
| CPTAC.C3N-00383 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-00386 |
<NA> |
<NA> |
<NA> |
human |
1972 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00388 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00389 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00390 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-00433 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-00435 |
<NA> |
<NA> |
<NA> |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, chest, kidney, paraaortic body, right kidney] |
[] |
| CPTAC.C3N-00437 |
<NA> |
<NA> |
White |
human |
1946 |
2021 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[abdomen, blood, kidney, left adrenal gland, left kidney, right kidney] |
[] |
| CPTAC.C3N-00439 |
<NA> |
<NA> |
White |
human |
1946 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00440 |
<NA> |
<NA> |
White |
human |
1962 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00491 |
Non-Cancer Related Death |
<NA> |
White |
human |
1962 |
2016 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[abdomen, blood, kidney, liver, right kidney] |
[] |
| CPTAC.C3N-00492 |
<NA> |
<NA> |
White |
human |
1967 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-00494 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left kidney, pelvic region of trunk, urinary bladder] |
[] |
| CPTAC.C3N-00495 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00520 |
Cancer-Related Death |
<NA> |
White |
human |
1957 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00545 |
<NA> |
<NA> |
Asian |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00546 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00547 |
<NA> |
<NA> |
Asian |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00549 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00550 |
<NA> |
<NA> |
Asian |
human |
1964 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00551 |
<NA> |
<NA> |
Asian |
human |
1962 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00552 |
<NA> |
<NA> |
Asian |
human |
1967 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00556 |
<NA> |
<NA> |
Asian |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00559 |
<NA> |
<NA> |
Asian |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00560 |
<NA> |
<NA> |
Asian |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00572 |
<NA> |
<NA> |
Asian |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-00573 |
<NA> |
<NA> |
Asian |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3N-00574 |
<NA> |
<NA> |
Asian |
human |
1976 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00577 |
<NA> |
<NA> |
Asian |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3N-00578 |
<NA> |
<NA> |
Asian |
human |
1968 |
2016 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00579 |
<NA> |
<NA> |
Asian |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00580 |
<NA> |
<NA> |
Asian |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-00646 |
<NA> |
<NA> |
White |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00647 |
<NA> |
<NA> |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-00704 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung, postcranial axial skeleton] |
[] |
| CPTAC.C3N-00715 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-00721 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-00729 |
<NA> |
Non-Hispanic |
White |
human |
1930 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[abdomen, blood, chest, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00732 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, chest, hepatic lymph node, left pelvic girdle region, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-00733 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, chest, kidney, liver, spleen] |
[] |
| CPTAC.C3N-00734 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, chest, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00737 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-00738 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-00743 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[] |
| CPTAC.C3N-00750 |
<NA> |
Hispanic or Latino |
White |
human |
1972 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-00753 |
<NA> |
Non-Hispanic |
Asian |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-00755 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1975 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-00831 |
Cancer-Related Death |
<NA> |
White |
human |
1964 |
2017 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-00832 |
<NA> |
<NA> |
White |
human |
1937 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left adrenal gland, left kidney, right adrenal gland] |
[] |
| CPTAC.C3N-00834 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-00836 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00847 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy] |
| CPTAC.C3N-00848 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00850 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00852 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-00858 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, left adrenal gland, pelvic lymph node, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00859 |
<NA> |
<NA> |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-00860 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00866 |
<NA> |
Non-Hispanic |
White |
human |
1939 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, left adrenal gland, left kidney, uterus] |
[] |
| CPTAC.C3N-00872 |
<NA> |
<NA> |
White |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00880 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-00953 |
<NA> |
Non-Hispanic |
Asian |
human |
1975 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[abdomen, blood, chest, kidney, left kidney] |
[] |
| CPTAC.C3N-00958 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[abdomen, blood, kidney] |
[] |
| CPTAC.C3N-00959 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[abdomen, blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01003 |
Cancer-Related Death |
<NA> |
White |
human |
1943 |
2018 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[abdomen, blood, left adrenal gland, pelvic region of trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01007 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01008 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01016 |
<NA> |
<NA> |
Asian |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01019 |
<NA> |
<NA> |
Asian |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01021 |
<NA> |
<NA> |
Asian |
human |
1973 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01022 |
<NA> |
<NA> |
Asian |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-01023 |
<NA> |
<NA> |
Asian |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01024 |
<NA> |
<NA> |
Asian |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01030 |
<NA> |
<NA> |
Asian |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01071 |
<NA> |
<NA> |
Asian |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-01072 |
<NA> |
<NA> |
Asian |
human |
1954 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01074 |
Non-Cancer Related Death |
<NA> |
Asian |
human |
1960 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-01077 |
<NA> |
<NA> |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01078 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01079 |
<NA> |
<NA> |
White |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-01080 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01081 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01082 |
<NA> |
<NA> |
White |
human |
1965 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01083 |
<NA> |
<NA> |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01085 |
<NA> |
<NA> |
White |
human |
1974 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01086 |
<NA> |
<NA> |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01088 |
<NA> |
<NA> |
White |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01090 |
<NA> |
<NA> |
White |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01091 |
<NA> |
<NA> |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-01171 |
Cardiovascular Disorder |
<NA> |
White |
human |
1934 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01172 |
<NA> |
<NA> |
White |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, liver, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01175 |
<NA> |
<NA> |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01176 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01178 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-01179 |
<NA> |
<NA> |
White |
human |
1944 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01180 |
<NA> |
<NA> |
White |
human |
1965 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-01200 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1960 |
2017 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01211 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01212 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01213 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Epithelial tumor, benign, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01214 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, kidney] |
[] |
| CPTAC.C3N-01217 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01219 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, pelvic region of trunk, retroperitoneal space, trunk, uterus] |
[] |
| CPTAC.C3N-01220 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1965 |
2018 |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01261 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-01267 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01341 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, left ovary, pelvic region of trunk, right ovary, uterus] |
[] |
| CPTAC.C3N-01342 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, lymph node, pelvic region of trunk, trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01344 |
Non-Cancer Related Death |
<NA> |
White |
human |
1937 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[] |
| CPTAC.C3N-01346 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, liver, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01349 |
Cancer-Related Death |
<NA> |
White |
human |
1939 |
2018 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, left adrenal gland, pelvic region of trunk, right adrenal gland, uterus] |
[] |
| CPTAC.C3N-01361 |
<NA> |
<NA> |
White |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-01405 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01408 |
<NA> |
<NA> |
Asian |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01409 |
<NA> |
<NA> |
Asian |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01410 |
<NA> |
<NA> |
Asian |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01413 |
<NA> |
<NA> |
Asian |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01414 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01415 |
<NA> |
<NA> |
Asian |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01416 |
<NA> |
<NA> |
Asian |
human |
1950 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01417 |
<NA> |
<NA> |
Asian |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01419 |
<NA> |
<NA> |
Asian |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01488 |
<NA> |
<NA> |
Asian |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-01489 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01510 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, chest, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01520 |
Non-Cancer Related Death |
<NA> |
<NA> |
human |
1947 |
2017 |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01521 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01522 |
<NA> |
<NA> |
<NA> |
human |
1936 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-01524 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[blood, chest, kidney, left lung, lung] |
[] |
| CPTAC.C3N-01525 |
<NA> |
<NA> |
<NA> |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-01526 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-01529 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-01536 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, left kidney, right kidney] |
[Chemotherapy] |
| CPTAC.C3N-01537 |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[] |
| CPTAC.C3N-01646 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-01648 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[abdomen, blood, kidney, left kidney, retroperitoneal lymph node] |
[] |
| CPTAC.C3N-01649 |
<NA> |
<NA> |
White |
human |
1965 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01651 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[abdomen, blood, kidney, left kidney, retroperitoneal lymph node] |
[] |
| CPTAC.C3N-01654 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[abdomen, blood, kidney, left adrenal gland, right kidney] |
[] |
| CPTAC.C3N-01655 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-01656 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-01657 |
<NA> |
<NA> |
White |
human |
1942 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-01761 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01764 |
<NA> |
<NA> |
White |
human |
1943 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01765 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, left pelvic girdle region, pelvic region of trunk, right pelvic girdle region, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01766 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01799 |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[abdomen, blood, chest, lung] |
[Chemotherapy] |
| CPTAC.C3N-01802 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1932 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, chest, parietal pelvic lymph node, pelvic region of trunk, retroperitoneal lymph node, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01803 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[abdomen, blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-01806 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, right kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3N-01808 |
<NA> |
Non-Hispanic |
White |
human |
1969 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Neoplasm, malignant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-01823 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1953 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-01825 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-01828 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[blood, bone tissue, chest, humerus, kidney, mediastinal lymph node, right lung, trunk] |
[Chemotherapy] |
| CPTAC.C3N-01830 |
<NA> |
<NA> |
<NA> |
human |
1943 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01842 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-01843 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, left adrenal gland, retroperitoneal lymph node, right adrenal gland, trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01847 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-01848 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01871 |
<NA> |
<NA> |
White |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01873 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, inguinal lymph node, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01874 |
Non-Cancer Related Death |
<NA> |
White |
human |
1932 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, right adrenal gland, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01875 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01876 |
<NA> |
<NA> |
White |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01877 |
Cancer-Related Death |
<NA> |
White |
human |
1943 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, left pelvic girdle region, parietal pelvic lymph node, pelvic region of trunk, uterus] |
[Chemotherapy] |
| CPTAC.C3N-01878 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, hepatic lymph node, pelvic region of trunk, retroperitoneal lymph node, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-01879 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-01880 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-01902 |
Cancer-Related Death |
<NA> |
White |
human |
1953 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, left adrenal gland, left kidney, retroperitoneal lymph node] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-01903 |
<NA> |
<NA> |
White |
human |
1969 |
<NA> |
[GDC, PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-01905 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, right adrenal gland, right kidney, trunk] |
[] |
| CPTAC.C3N-01989 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[abdomen, blood, chest, kidney, left adrenal gland, left kidney, liver, right lung] |
[] |
| CPTAC.C3N-02000 |
<NA> |
<NA> |
Asian |
human |
1971 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02002 |
<NA> |
<NA> |
Asian |
human |
1940 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02003 |
<NA> |
<NA> |
Asian |
human |
1960 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02005 |
<NA> |
<NA> |
Asian |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02012 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, chest, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-02015 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-02027 |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02028 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02030 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02061 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02062 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02063 |
<NA> |
<NA> |
<NA> |
human |
1967 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-02066 |
<NA> |
<NA> |
Asian |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[blood, kidney] |
[Chemotherapy] |
| CPTAC.C3N-02067 |
<NA> |
<NA> |
Asian |
human |
1979 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02068 |
<NA> |
<NA> |
Asian |
human |
1969 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02070 |
<NA> |
<NA> |
Asian |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02082 |
<NA> |
<NA> |
Asian |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02084 |
<NA> |
<NA> |
Asian |
human |
1964 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02085 |
<NA> |
<NA> |
Asian |
human |
1971 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02087 |
Cancer-Related Death |
<NA> |
Asian |
human |
1956 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02088 |
<NA> |
<NA> |
Asian |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02089 |
<NA> |
<NA> |
Asian |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02090 |
<NA> |
<NA> |
Asian |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02141 |
<NA> |
<NA> |
Asian |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02142 |
<NA> |
<NA> |
Asian |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02143 |
<NA> |
<NA> |
Asian |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[blood, lung] |
[] |
| CPTAC.C3N-02144 |
<NA> |
<NA> |
Asian |
human |
1946 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02145 |
<NA> |
<NA> |
Asian |
human |
1949 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02146 |
<NA> |
<NA> |
Asian |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02149 |
<NA> |
<NA> |
Asian |
human |
1953 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-02150 |
<NA> |
<NA> |
Asian |
human |
1968 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02152 |
<NA> |
<NA> |
Asian |
human |
1957 |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-02153 |
<NA> |
<NA> |
Asian |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02155 |
<NA> |
<NA> |
Asian |
human |
1972 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02158 |
<NA> |
<NA> |
Asian |
human |
1963 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02160 |
<NA> |
<NA> |
Asian |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-02192 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02193 |
<NA> |
Non-Hispanic |
White |
human |
1938 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-02224 |
<NA> |
<NA> |
White |
human |
1975 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-02230 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-02234 |
<NA> |
<NA> |
Asian |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02237 |
<NA> |
<NA> |
Asian |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-02240 |
<NA> |
<NA> |
Asian |
human |
1968 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-02242 |
<NA> |
<NA> |
Asian |
human |
1970 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02244 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-02247 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-02248 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[blood, kidney] |
[] |
| CPTAC.C3N-02249 |
<NA> |
Hispanic or Latino |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-02253 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[] |
[blood, uterus] |
[] |
| CPTAC.C3N-02262 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, abdominal wall, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-02263 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-02264 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-02265 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[abdomen, blood, kidney, left kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02266 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-02271 |
<NA> |
<NA> |
White |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02274 |
Non-Cancer Related Death |
<NA> |
White |
human |
1936 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02281 |
<NA> |
<NA> |
White |
human |
1953 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02282 |
<NA> |
<NA> |
White |
human |
1953 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02290 |
Cancer-Related Death |
<NA> |
White |
human |
1966 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, chest, lung] |
[Chemotherapy] |
| CPTAC.C3N-02296 |
Non-Cancer Related Death |
<NA> |
White |
human |
1934 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[blood, uterus] |
[] |
| CPTAC.C3N-02298 |
<NA> |
<NA> |
White |
human |
1934 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, hepatic lymph node, trunk, uterus] |
[] |
| CPTAC.C3N-02302 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02332 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female, male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-02337 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02338 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-02372 |
<NA> |
<NA> |
<NA> |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[] |
| CPTAC.C3N-02379 |
<NA> |
<NA> |
Asian |
human |
1960 |
2018 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02380 |
<NA> |
<NA> |
Asian |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02421 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02422 |
Cancer-Related Death |
<NA> |
Asian |
human |
1961 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02423 |
<NA> |
<NA> |
Asian |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02424 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02429 |
<NA> |
<NA> |
Asian |
human |
1975 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02431 |
<NA> |
<NA> |
Asian |
human |
1970 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02433 |
<NA> |
<NA> |
Asian |
human |
1948 |
2020 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02436 |
<NA> |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, chest, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-02437 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage III] |
[abdomen, blood, chest, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02439 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[abdomen, blood, kidney, left kidney] |
[] |
| CPTAC.C3N-02440 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
1952 |
2020 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[Stage II] |
[abdomen, blood, kidney] |
[] |
| CPTAC.C3N-02451 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[blood, chest, lung] |
[Chemotherapy] |
| CPTAC.C3N-02529 |
<NA> |
<NA> |
Asian |
human |
1938 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02572 |
<NA> |
<NA> |
Asian |
human |
1968 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02577 |
<NA> |
<NA> |
Asian |
human |
1969 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02582 |
<NA> |
<NA> |
Asian |
human |
1940 |
2020 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02586 |
Surgical Complication |
<NA> |
Asian |
human |
1943 |
2017 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02587 |
<NA> |
<NA> |
Asian |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02588 |
<NA> |
<NA> |
Asian |
human |
1948 |
2020 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IV] |
[blood, lung] |
[] |
| CPTAC.C3N-02595 |
<NA> |
<NA> |
White |
human |
1976 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[abdomen, blood, parietal pelvic lymph node, pelvic region of trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02598 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IV] |
[abdomen, blood, chest, liver, retroperitoneal lymph node, uterus] |
[Chemotherapy] |
| CPTAC.C3N-02631 |
Cancer-Related Death |
<NA> |
White |
human |
1940 |
2021 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Chemotherapy] |
| CPTAC.C3N-02632 |
<NA> |
<NA> |
White |
human |
1959 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[] |
| CPTAC.C3N-02635 |
<NA> |
<NA> |
White |
human |
1960 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, abdominopelvic cavity, blood, lumbar lymph node, pelvic lymph node, pelvic region of trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02636 |
Infection |
<NA> |
White |
human |
1944 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02637 |
<NA> |
<NA> |
White |
human |
1964 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, abdominopelvic cavity, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02639 |
Cancer-Related Death |
<NA> |
White |
human |
1958 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, trunk, uterus, vertebra] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| CPTAC.C3N-02672 |
<NA> |
<NA> |
White |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02678 |
Cancer-Related Death |
<NA> |
White |
human |
1947 |
2019 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02715 |
<NA> |
<NA> |
<NA> |
human |
1980 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02718 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02721 |
<NA> |
<NA> |
<NA> |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, chest, lung] |
[Chemotherapy] |
| CPTAC.C3N-02723 |
Surgical Complication |
<NA> |
<NA> |
human |
1931 |
2017 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[abdomen, abdominal cavity, blood, chest, inferior vena cava, kidney, right kidney, right lung] |
[] |
| CPTAC.C3N-02726 |
<NA> |
<NA> |
<NA> |
human |
1964 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[blood, kidney] |
[] |
| CPTAC.C3N-02728 |
<NA> |
<NA> |
<NA> |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02729 |
<NA> |
<NA> |
Asian |
human |
1971 |
2019 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02757 |
<NA> |
<NA> |
Asian |
human |
1948 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02758 |
<NA> |
<NA> |
Asian |
human |
1940 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02761 |
<NA> |
<NA> |
Asian |
human |
1986 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02763 |
<NA> |
<NA> |
Asian |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02764 |
<NA> |
<NA> |
Asian |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02789 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, blood, chest, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-02811 |
<NA> |
Non-Hispanic |
White |
human |
1942 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, kidney, right kidney] |
[] |
| CPTAC.C3N-02818 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
2021 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[blood, chest, kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines)] |
| CPTAC.C3N-02828 |
<NA> |
<NA> |
Asian |
human |
1992 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[blood, lung] |
[] |
| CPTAC.C3N-02916 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02919 |
<NA> |
<NA> |
Asian |
human |
1960 |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02920 |
<NA> |
<NA> |
Asian |
human |
1969 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02922 |
<NA> |
<NA> |
Asian |
human |
1963 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02923 |
<NA> |
<NA> |
Asian |
human |
1958 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-02926 |
<NA> |
<NA> |
Asian |
human |
1967 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3N-02928 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-02929 |
<NA> |
<NA> |
Asian |
human |
1959 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3N-02945 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[blood, kidney] |
[] |
| CPTAC.C3N-02947 |
<NA> |
Non-Hispanic |
White |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, chest, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02948 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-02950 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1945 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[abdomen, blood, chest, lung] |
[] |
| CPTAC.C3N-02972 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
1942 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIC1] |
[abdomen, blood, chest, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02973 |
<NA> |
Non-Hispanic |
White |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-02976 |
<NA> |
<NA> |
White |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, liver, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02978 |
<NA> |
<NA> |
White |
human |
1951 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02979 |
<NA> |
<NA> |
White |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, adrenal gland, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-02994 |
<NA> |
<NA> |
White |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-03005 |
Non-Cancer Related Death |
<NA> |
White |
human |
1926 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, abdominopelvic cavity, blood, liver, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-03018 |
<NA> |
<NA> |
White |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, blood, hepatic lymph node, kidney, liver, right kidney] |
[] |
| CPTAC.C3N-03019 |
<NA> |
<NA> |
White |
human |
1971 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[abdomen, axillary lymph node, blood, chest, kidney, mediastinal lymph node, right kidney] |
[] |
| CPTAC.C3N-03020 |
Infection |
<NA> |
White |
human |
1952 |
2021 |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-03021 |
<NA> |
<NA> |
White |
human |
1967 |
<NA> |
[GDC, IDC, PDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[blood, kidney] |
[] |
| CPTAC.C3N-03038 |
<NA> |
Non-Hispanic |
White |
human |
1971 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-03052 |
<NA> |
<NA> |
Asian |
human |
1955 |
2020 |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03054 |
<NA> |
<NA> |
Asian |
human |
1945 |
2018 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA3] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03057 |
<NA> |
<NA> |
Asian |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03063 |
<NA> |
<NA> |
Asian |
human |
1955 |
2020 |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03073 |
<NA> |
<NA> |
Asian |
human |
1949 |
2022 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-03074 |
<NA> |
<NA> |
Asian |
human |
1964 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03080 |
<NA> |
<NA> |
Asian |
human |
1950 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-03202 |
<NA> |
<NA> |
Asian |
human |
1949 |
2021 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA2] |
[blood, lung] |
[] |
| CPTAC.C3N-03205 |
<NA> |
<NA> |
Asian |
human |
1974 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03210 |
<NA> |
<NA> |
Asian |
human |
1966 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA3] |
[blood, lung] |
[] |
| CPTAC.C3N-03212 |
<NA> |
<NA> |
Asian |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03222 |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-03225 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[] |
| CPTAC.C3N-03233 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, chest, lung] |
[] |
| CPTAC.C3N-03238 |
<NA> |
<NA> |
<NA> |
human |
1970 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[blood, lung] |
[] |
| CPTAC.C3N-03415 |
Non-Cancer Related Death |
<NA> |
White |
human |
1932 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-03417 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[abdomen, blood, pelvic region of trunk, uterus] |
[Radiation Therapy, NOS] |
| CPTAC.C3N-03420 |
<NA> |
<NA> |
White |
human |
1951 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[blood, lung] |
[] |
| CPTAC.C3N-03764 |
Cancer-Related Death |
<NA> |
White |
human |
1949 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03765 |
Cancer-Related Death |
<NA> |
White |
human |
1957 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-03767 |
Cancer-Related Death |
<NA> |
White |
human |
1951 |
2020 |
[GDC, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, abdominopelvic cavity, blood, pelvic region of trunk, uterus] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-03890 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy] |
| CPTAC.C3N-03911 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[abdomen, blood, chest, lung] |
[] |
| CPTAC.C3N-03921 |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-03929 |
<NA> |
<NA> |
<NA> |
human |
1967 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-04157 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[blood, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| CPTAC.C3N-04168 |
<NA> |
<NA> |
<NA> |
human |
1967 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[blood, lung] |
[] |
| CPTAC.C3N-04173 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[abdomen, blood, chest, lung] |
[Chemotherapy] |
| CPTAC.C3N-04176 |
<NA> |
<NA> |
White |
human |
1955 |
2019 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-04180 |
<NA> |
<NA> |
White |
human |
1947 |
2020 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[] |
| CPTAC.C3N-04382 |
<NA> |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[blood, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| EXCEPTIONAL_RESPONDERS.ER-ABDN |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Hepatoid adenocarcinoma] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABDX |
<NA> |
<NA> |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABEO |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABNX |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABO1 |
<NA> |
Non-Hispanic |
White |
human |
1981 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABO4 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABOM |
<NA> |
Non-Hispanic |
White |
human |
1945 |
2018 |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABON |
<NA> |
Non-Hispanic |
<NA> |
human |
1943 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABOT |
<NA> |
Non-Hispanic |
White |
human |
1932 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABS8 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABSE |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABV2 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABV6 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ABXO |
<NA> |
Non-Hispanic |
Black or African American |
human |
1945 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AC3P |
<NA> |
Non-Hispanic |
White |
human |
1943 |
2016 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AC6N |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ACGR |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AD0G |
<NA> |
Non-Hispanic |
White |
human |
1938 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AD0W |
<NA> |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AD3D |
<NA> |
Non-Hispanic |
Asian |
human |
1958 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AD7D |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage 0, Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AD8S |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ADIN |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ADRU |
<NA> |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-ADXD |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE02 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE2I |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE6D |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE8R |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE8U |
<NA> |
Non-Hispanic |
White |
human |
1936 |
2013 |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AE91 |
<NA> |
Non-Hispanic |
White |
human |
1937 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AEK6 |
<NA> |
Non-Hispanic |
White |
human |
1934 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage I, Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AEND |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AFAH |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I, Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-AFFX |
<NA> |
Non-Hispanic |
White |
human |
1966 |
2015 |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0AP |
<NA> |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0AT |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0BH |
<NA> |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0BV |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0CR |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0FX |
<NA> |
Non-Hispanic |
Black or African American |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0GE |
<NA> |
Hispanic or Latino |
<NA> |
human |
1968 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0GF |
<NA> |
Non-Hispanic |
<NA> |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0GI |
<NA> |
Non-Hispanic |
<NA> |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0GM |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[] |
| EXCEPTIONAL_RESPONDERS.ER-B0HF |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB, Stage IV] |
[] |
[] |
| FM.AD1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10011 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10018 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10036 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10041 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10065 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10094 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10109 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10142 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10143 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10145 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10151 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10171 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10174 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10228 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10262 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10267 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10271 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10285 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10286 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1030 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10321 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10331 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10346 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10367 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10382 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10392 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10399 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1041 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10414 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10477 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10500 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10505 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10569 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10573 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1058 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10580 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10628 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10650 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10652 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10661 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10665 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10671 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10683 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10735 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10753 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10756 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10757 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10763 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10784 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10787 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10789 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1084 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10847 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10850 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10860 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10866 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10878 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD109 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1090 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10902 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10924 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10927 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1095 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10984 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD10993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD10998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD11026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11040 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11048 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11073 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11094 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11095 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1110 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11108 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11110 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11153 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11170 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11172 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11210 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11246 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1126 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11262 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11274 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11284 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11288 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11316 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1133 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11349 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11365 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11368 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11371 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11374 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD11427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11431 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11494 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11510 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11519 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11573 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11580 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11600 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11610 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11613 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11628 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11665 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11687 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1170 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11738 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11751 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11792 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11799 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11823 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1183 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11849 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11854 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11857 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11897 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11905 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1194 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11940 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11958 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD11984 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD11988 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD11997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12018 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12082 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD12085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12090 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12095 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12108 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12110 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12113 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12135 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1215 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12171 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12172 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12176 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12187 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12188 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12252 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1229 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12308 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12317 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12341 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12349 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12362 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12369 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12401 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12440 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12452 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12477 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12487 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12494 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12510 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1252 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12576 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12580 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12582 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12583 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12614 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1262 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12631 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12661 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12698 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12699 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12702 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12735 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12769 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12778 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12787 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12789 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12794 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12805 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12829 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12847 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12937 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1298 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD12988 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12995 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD12998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1305 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13065 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13073 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13084 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13109 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13111 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13113 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13143 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD13151 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1316 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13170 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13174 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13176 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13187 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13192 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13197 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13203 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1321 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13229 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13242 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13243 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1327 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13270 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13274 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13308 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13326 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13328 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13363 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13383 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13401 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1341 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13414 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD13526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13552 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13573 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13577 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13583 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13600 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13613 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13614 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13631 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13648 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13655 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13668 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13672 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13683 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13687 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13694 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13695 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1371 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13739 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13746 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13748 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13757 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13769 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD13794 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13798 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13817 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13818 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13846 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13849 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13853 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13868 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13902 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13919 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1392 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13937 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13939 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13958 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13984 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1399 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD13992 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD13994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14030 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14185 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14192 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14194 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14197 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD142 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14261 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14271 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14286 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14305 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14325 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14368 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14372 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14392 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD14409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14429 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14484 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14505 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD14536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14539 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14552 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14557 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14573 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14583 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14671 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14677 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14686 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14692 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14695 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14699 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14707 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14711 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14746 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14751 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14773 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14780 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14796 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14799 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14823 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14825 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14829 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14846 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14866 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14887 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14897 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD149 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14933 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14937 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14939 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14953 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD14985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD14991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15030 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15036 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15040 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15058 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15067 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15073 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15076 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD151 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1510 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15108 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15126 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15133 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15149 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15172 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1519 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15201 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD15205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15224 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15229 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15242 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15251 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15267 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15272 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15273 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15284 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15285 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD153 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15308 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1531 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD1532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15326 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15341 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15346 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15358 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15374 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15383 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15399 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15456 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15477 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15500 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15505 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15552 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15572 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15626 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15643 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15650 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15653 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15659 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15661 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15664 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15672 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15687 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15698 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15699 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15702 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15707 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15711 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD15721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15739 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15746 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15757 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15763 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15766 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15778 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15784 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15791 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15799 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15818 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15825 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15847 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15866 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15872 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15897 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15933 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15967 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD15992 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD15999 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1600 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16082 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16084 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD161 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1610 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1613 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD16130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16171 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16183 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16228 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16251 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16267 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16272 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16273 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16298 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16305 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16327 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16328 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16331 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1634 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16354 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1636 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16363 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16367 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16440 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16451 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16529 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16539 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16557 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16571 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16572 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16576 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16580 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16583 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16594 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16610 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16613 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16634 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16637 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16666 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16671 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16683 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16686 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD16690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16695 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16699 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16702 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16711 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1672 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16720 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16730 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16738 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16740 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16757 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16763 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16764 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16778 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16791 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16805 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16817 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16822 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16830 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16843 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16853 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1686 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16905 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16927 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16933 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16939 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16953 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD16989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD16990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD16996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17036 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17084 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17102 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17110 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17111 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17113 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17137 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1714 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17143 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17153 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17176 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17185 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17195 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17203 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17210 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17215 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17224 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17229 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17237 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17251 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17262 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17270 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17273 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17288 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17298 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17299 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17317 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17358 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17362 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17368 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17369 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17376 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1739 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1740 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17401 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1741 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17429 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17440 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17451 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17484 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17487 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17500 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17525 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1753 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17552 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17573 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17577 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17582 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD176 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17626 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17652 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17668 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17671 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1769 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17707 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1771 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17738 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17746 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17748 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17753 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD17763 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17764 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17773 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17780 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17791 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD17792 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17794 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17822 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17850 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17854 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17857 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17868 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17887 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17902 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1792 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17940 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17953 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD17988 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD17998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD18001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD18004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD1817 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1825 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1843 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1897 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD19 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1924 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1933 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD1994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD1995 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2011 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD2020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2040 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2041 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2048 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2067 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2076 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD2130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2143 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD215 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD216 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2201 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2224 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD224 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD2259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD2264 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2271 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2272 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD228 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2284 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2298 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD23 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2317 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2331 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2346 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2354 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2363 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2369 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD243 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2452 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2487 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD2496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2539 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2571 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2582 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD261 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2614 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2628 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2634 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2636 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD264 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2643 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2666 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD267 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2672 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2677 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2686 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2694 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2702 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2714 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2754 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2771 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2773 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2789 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2799 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2805 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2813 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD284 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2849 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD286 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2866 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD2870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2887 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD29 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2905 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2924 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD2949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD2973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD298 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD2995 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3011 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3048 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3094 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3096 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3105 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3119 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3135 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD316 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3170 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3174 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3188 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3194 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3195 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD321 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3219 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3237 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3251 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3252 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD326 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3267 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD327 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3272 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3274 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3288 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD3292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD33 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3321 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3326 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3327 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3338 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3365 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3371 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3376 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD34 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3414 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD349 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD3507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3552 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD358 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3582 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3594 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD3601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD362 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3626 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3628 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3637 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3653 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3664 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3666 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3668 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD368 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD372 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3730 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3740 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3757 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD376 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3766 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3778 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3792 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3818 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3822 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3823 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3878 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3884 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3902 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3919 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD392 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3953 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3984 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3992 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3995 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD3998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD3999 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4065 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4069 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4094 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4106 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4111 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4145 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD4160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4171 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4192 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4195 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4213 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4237 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4242 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4243 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4264 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4285 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4308 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD4312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4315 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4316 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4341 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4346 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4374 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4380 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4387 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4392 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4399 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4401 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4414 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4446 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD445 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD4459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD447 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4557 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4576 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD461 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4636 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4637 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4643 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4654 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD4661 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4665 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4683 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4692 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4698 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4738 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4739 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4740 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4759 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4764 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4766 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD478 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD4785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4790 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4794 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4818 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4823 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4829 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4847 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4868 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4872 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4876 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4884 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD49 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4905 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD494 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD4993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD4998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5000 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5036 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5040 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5041 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5046 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD505 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5109 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5110 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5126 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5135 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5161 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5172 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD5182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5185 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD5187 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD519 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5192 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5197 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5210 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5216 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5222 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5223 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5237 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5246 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD525 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5251 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5270 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5274 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5287 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD529 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5299 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD53 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5325 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5331 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5350 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5363 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5365 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5366 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD54 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5433 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5456 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5487 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD55 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5505 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD551 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5519 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5525 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5550 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5557 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5571 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5572 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5580 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD5612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5613 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5641 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5643 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5664 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5669 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5692 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5694 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5695 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD572 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5751 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5754 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5756 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5759 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD576 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5764 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5771 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5787 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5794 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD58 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5813 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5822 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5846 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD585 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD5858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5884 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD59 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5924 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5928 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5937 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5953 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5958 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5967 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5988 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD5997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD5998 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD60 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6012 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6041 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6055 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6058 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6065 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6067 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6075 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6076 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6091 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6092 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD61 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6111 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6120 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6135 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6141 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6142 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6157 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD616 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6161 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6162 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6174 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6185 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6197 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| FM.AD6200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6201 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6210 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6220 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6226 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6228 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6231 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6237 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6243 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6254 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD626 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6260 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6261 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6264 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6268 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6273 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6278 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6286 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6296 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6299 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6303 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6308 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6310 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6328 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6330 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6340 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6345 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6353 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6354 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6363 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6372 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6375 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6376 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6429 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6431 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6446 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6452 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6456 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6461 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6467 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD648 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6499 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6500 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD651 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6531 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6539 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6554 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6557 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6558 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6569 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6571 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6600 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6620 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6628 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6648 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD665 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6664 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6695 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6720 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6730 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6738 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6740 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6741 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6748 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6752 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6778 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6784 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6791 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6829 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6843 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6849 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6853 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6857 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6911 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6916 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6934 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD694 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6967 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD6987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6992 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD6999 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7018 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD704 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD705 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7066 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7067 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7072 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7073 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7080 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7082 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7088 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7090 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD71 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7104 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7105 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7118 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD7121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7137 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7143 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7149 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7150 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7152 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7154 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7159 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7171 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7174 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7182 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7188 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7190 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD72 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7208 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7209 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7216 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7218 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7227 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7236 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7246 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7253 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7270 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7274 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7277 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7280 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7285 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7289 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7294 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7297 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7323 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7324 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7328 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7332 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7337 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7342 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7358 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7362 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7370 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7376 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7383 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7386 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7388 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7391 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7394 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD74 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7409 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD741 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD743 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7473 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7485 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7486 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7491 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7497 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD75 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7500 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7503 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD751 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7528 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7531 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7536 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7541 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD755 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD756 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7563 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7564 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7567 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7569 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7574 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7588 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7594 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7621 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7622 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7624 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7625 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD763 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD764 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7642 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7657 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7666 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7668 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD769 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7690 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7707 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7711 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7720 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7736 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7746 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7748 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7753 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD776 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7766 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7769 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7770 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7777 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7785 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7796 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7797 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7798 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7805 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7809 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7813 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7818 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7824 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7825 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7828 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7830 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7834 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD784 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7843 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7849 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7854 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7868 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7876 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7878 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7884 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7889 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7904 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7920 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7927 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7937 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7939 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD795 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7958 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD796 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7964 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD7985 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7988 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD7997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD8031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8048 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8049 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8057 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8063 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8064 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8065 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8078 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD808 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8090 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8097 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8101 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8103 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8105 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8111 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8113 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8116 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8123 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8126 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD813 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8139 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8144 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8148 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8155 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8166 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8168 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD817 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8175 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8180 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8181 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8186 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8187 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8192 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8194 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8198 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8200 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8201 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8202 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8204 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8216 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8233 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8235 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8238 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8240 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8242 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8243 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD825 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8252 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8255 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8256 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8257 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8258 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8259 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8270 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8279 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8283 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8284 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8288 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8295 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8299 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD830 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD8301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adnexal adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8302 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8316 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8322 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8336 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8346 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8354 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8357 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8359 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8362 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8365 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8369 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8377 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8378 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8381 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8400 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8401 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8408 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8411 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8413 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8419 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8421 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8429 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8435 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8439 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8448 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8457 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8461 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8463 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8471 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD848 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8480 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8481 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8483 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8484 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8490 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8493 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8494 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8501 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8510 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8512 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8518 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8523 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8525 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8526 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8529 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8533 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8535 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8539 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8540 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8545 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| FM.AD8546 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8559 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8569 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD857 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8572 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8589 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8594 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8595 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8596 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8597 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8610 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8629 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8630 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8633 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8634 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8636 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8637 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8638 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8647 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD865 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8650 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8653 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8656 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8658 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8659 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8664 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8666 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8668 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8670 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8676 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8677 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD868 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8683 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8689 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8692 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8707 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8710 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8714 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD872 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8729 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8737 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8739 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8750 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8754 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8758 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8761 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8762 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8768 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8779 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8780 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8784 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8799 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD880 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8802 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8807 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8816 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8820 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8822 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8826 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8840 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8860 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8864 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8872 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8874 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8876 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8879 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8899 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8917 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8945 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD895 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8967 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD897 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8978 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8987 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8989 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD8991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD8999 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD90 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD900 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9011 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9014 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9026 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD903 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9037 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9040 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9044 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9047 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9058 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9067 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9068 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9070 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9071 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9074 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9077 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9079 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD908 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9081 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9083 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9085 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9086 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9087 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9089 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9090 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9093 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9098 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9099 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD910 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9100 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9107 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9109 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9112 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9114 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9115 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9117 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9121 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9124 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9127 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9133 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9138 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9140 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9145 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9149 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9156 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9158 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9160 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9163 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9164 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9165 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9167 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9169 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9173 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9176 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9177 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9178 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9179 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD918 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9183 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9184 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9185 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9187 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9189 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD919 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9191 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9193 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9194 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9195 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9196 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD9197 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9199 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9215 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9217 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9221 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9225 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9229 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD923 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9230 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9232 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9234 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9239 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9241 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9242 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9247 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9248 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD925 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD926 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9263 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9265 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9266 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9269 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD927 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9271 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9272 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9273 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9275 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9276 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9281 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9282 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9285 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9290 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9291 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9292 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9293 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9299 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9305 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9309 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9312 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9313 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9314 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9317 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9318 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9319 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD932 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9320 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9321 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9325 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9329 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD933 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9331 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9333 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9334 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9335 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9339 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD934 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9341 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9343 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9344 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9348 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9351 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9352 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9354 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9355 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9356 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD936 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9360 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9361 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[] |
[] |
[] |
| FM.AD9364 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9368 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9372 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9373 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9379 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9385 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9393 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9399 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD94 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9404 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9406 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9407 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9412 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9416 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD9424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9431 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD944 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9440 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9450 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9452 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9464 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9468 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| FM.AD947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| FM.AD9474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9479 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9482 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9484 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9498 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9504 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9513 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9515 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9525 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9531 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9534 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9561 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9565 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9566 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9568 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD957 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9570 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9571 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9576 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9577 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9579 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD958 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9584 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD959 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9590 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9593 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD96 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD960 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9603 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9604 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9606 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9614 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9615 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9617 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9618 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9619 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9623 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9627 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9630 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9632 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9634 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9635 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9636 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9639 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9644 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9645 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9646 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD965 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9650 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9652 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9655 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9659 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9671 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9674 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9682 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9684 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9691 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9694 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9698 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9700 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9701 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9702 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9703 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9706 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9708 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9709 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9730 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9741 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9744 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9745 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9747 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9749 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9754 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9759 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9760 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9765 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9767 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9771 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9772 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9774 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9775 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9781 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9782 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9783 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9786 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9787 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9788 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9789 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9791 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9793 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9796 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD98 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9800 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9801 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9803 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9804 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9806 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9813 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9817 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9827 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9829 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD983 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9832 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9835 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9836 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9838 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9839 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9843 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9846 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9847 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9850 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9859 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9863 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9871 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9873 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9876 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9886 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9888 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9905 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9907 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD991 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9913 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9914 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9915 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9922 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9929 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9931 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9935 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9938 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9942 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9943 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9946 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9948 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9951 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9954 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD996 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9961 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9962 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9963 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9969 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9974 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9981 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9986 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| FM.AD9990 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9993 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| FM.AD9997 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-BROD-0001-C18 |
Cancer-Related Death |
<NA> |
White |
human |
1963 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0008-C25 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0009-C25 |
<NA> |
Non-Hispanic |
White |
human |
1967 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0010-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0015-C25 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0016-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0019-C25 |
<NA> |
Non-Hispanic |
White |
human |
1935 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0020-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0025-C16 |
<NA> |
<NA> |
White |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0043-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0044-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1979 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0045-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0095-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1966 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, 3D Conformal, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0096-C15 |
Cancer-Related Death |
<NA> |
White |
human |
1965 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0097-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0098-C15 |
<NA> |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0099-C15 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0100-C15 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Surgery, NOS] |
| HCMI.HCM-BROD-0101-C15 |
Cancer-Related Death |
<NA> |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0108-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0110-C25 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0111-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0112-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0115-C16 |
<NA> |
Non-Hispanic |
White |
human |
1973 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, 2D Conventional, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0116-C16 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0118-C16 |
<NA> |
Non-Hispanic |
Asian |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0120-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0122-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0124-C25 |
Cancer-Related Death |
<NA> |
White |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Intensity-Modulated Radiotherapy, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0125-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1944 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0129-C25 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0130-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0131-C25 |
Cancer-Related Death |
Non-Hispanic |
<NA> |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0132-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0134-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0138-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0140-C16 |
Non-Cancer Related Death |
<NA> |
White |
human |
1933 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0194-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0204-C25 |
<NA> |
Non-Hispanic |
White |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0206-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0219-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0220-C15 |
<NA> |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0229-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0230-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1933 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0231-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0232-C25 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0235-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1967 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0253-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0328-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0344-C25 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0348-C25 |
<NA> |
<NA> |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0356-C16 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0411-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0413-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0414-C25 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0445-C15 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0448-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1939 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0450-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1965 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0451-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0453-C16 |
<NA> |
Non-Hispanic |
White |
human |
1978 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0458-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0475-C16 |
<NA> |
<NA> |
<NA> |
human |
1982 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0477-C16 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0478-C16 |
<NA> |
Non-Hispanic |
Asian |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0483-C16 |
<NA> |
Non-Hispanic |
White |
human |
1968 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0485-C15 |
<NA> |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0488-C16 |
<NA> |
<NA> |
White |
human |
1945 |
<NA> |
[GDC] |
[Tubular adenocarcinoma] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0489-C15 |
<NA> |
Non-Hispanic |
<NA> |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0555-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0559-C16 |
<NA> |
Non-Hispanic |
White |
human |
1994 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0568-C15 |
<NA> |
Non-Hispanic |
White |
human |
1954 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0577-C15 |
Cancer-Related Death |
Non-Hispanic |
<NA> |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0578-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1972 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0579-C16 |
<NA> |
Non-Hispanic |
White |
human |
1981 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0615-C16 |
<NA> |
Non-Hispanic |
<NA> |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0644-C25 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Small cell carcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Stereotactic Radiosurgery, Surgery, NOS] |
| HCMI.HCM-BROD-0703-C16 |
Cancer-Related Death |
Hispanic or Latino |
<NA> |
human |
1965 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0759-C15 |
<NA> |
Non-Hispanic |
<NA> |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0793-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0926-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1989 |
<NA> |
[GDC] |
[Tubular adenocarcinoma] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0953-C34 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Stereotactic Radiosurgery, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0954-C34 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0955-C15 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0957-C34 |
<NA> |
Non-Hispanic |
Asian |
human |
1972 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-BROD-0958-C56 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
1953 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0959-C18 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0960-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-0962-C16 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-1127-C15 |
<NA> |
Non-Hispanic |
White |
human |
1975 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-1128-C15 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-BROD-1186-C64 |
<NA> |
Non-Hispanic |
White |
human |
1971 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[Stage III] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0056-C18 |
<NA> |
Non-Hispanic |
White |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0057-C18 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Ablation, Radiofrequency, Chemotherapy, Immunotherapy (Including Vaccines), Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0058-C34 |
<NA> |
Non-Hispanic |
White |
human |
1934 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0060-C18 |
<NA> |
Non-Hispanic |
White |
human |
1966 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0061-C18 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0062-C18 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0063-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0064-C18 |
<NA> |
Non-Hispanic |
Asian |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0065-C20 |
<NA> |
Non-Hispanic |
Asian |
human |
1954 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0085-C24 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0141-C18 |
<NA> |
<NA> |
White |
human |
1950 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0142-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0143-C20 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1929 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0147-C24 |
Non-Cancer Related Death |
Hispanic or Latino |
<NA> |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0158-C20 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0159-C18 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0160-C18 |
<NA> |
Non-Hispanic |
White |
human |
1934 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0161-C18 |
<NA> |
Non-Hispanic |
White |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0162-C19 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0164-C20 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1966 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0237-C18 |
<NA> |
Non-Hispanic |
Asian |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0238-C18 |
<NA> |
Hispanic or Latino |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0239-C18 |
<NA> |
Non-Hispanic |
White |
human |
1963 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0241-C18 |
<NA> |
Non-Hispanic |
White |
human |
1929 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0242-C18 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0243-C18 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0244-C20 |
<NA> |
Non-Hispanic |
Asian |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0245-C18 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0246-C19 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Intensity-Modulated Radiotherapy, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0247-C18 |
<NA> |
Non-Hispanic |
White |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0248-C19 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1965 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0255-C18 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0257-C18 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0258-C18 |
<NA> |
<NA> |
<NA> |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0317-C18 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0318-C18 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0322-C20 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0323-C20 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Intensity-Modulated Radiotherapy, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0368-D37 |
<NA> |
Hispanic or Latino |
White |
human |
1952 |
<NA> |
[GDC] |
[Noninfiltrating intraductal papillary adenocarcinoma] |
[male] |
[Stage 0] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0377-C18 |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0378-C18 |
<NA> |
Non-Hispanic |
White |
human |
1969 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0379-C18 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, metastatic, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0380-C18 |
<NA> |
Non-Hispanic |
White |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0381-C20 |
<NA> |
Non-Hispanic |
White |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Intensity-Modulated Radiotherapy, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0382-C19 |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0383-C18 |
<NA> |
Non-Hispanic |
White |
human |
1967 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0385-C18 |
<NA> |
Non-Hispanic |
Asian |
human |
1936 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0432-C20 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0433-C24 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1966 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0434-C24 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0438-C18 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0459-C17 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0467-C56 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0507-C20 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0511-C24 |
<NA> |
<NA> |
<NA> |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0512-C24 |
<NA> |
<NA> |
<NA> |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0582-C18 |
Cancer-Related Death |
Hispanic or Latino |
White |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0584-C19 |
<NA> |
Non-Hispanic |
White |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0603-C18 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1946 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0606-C17 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0607-C19 |
<NA> |
<NA> |
<NA> |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0618-C18 |
<NA> |
<NA> |
<NA> |
human |
1934 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0621-C18 |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0622-C18 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1940 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0623-C18 |
<NA> |
<NA> |
<NA> |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0625-C18 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0653-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1962 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0658-C20 |
<NA> |
Non-Hispanic |
Asian |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0659-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1969 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0664-C18 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0666-C24 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS, Tubulovillous adenoma, NOS] |
[female] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0668-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0669-C18 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1976 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0670-C18 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0726-C18 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Small cell carcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0727-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1956 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0729-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1960 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0731-C19 |
<NA> |
Non-Hispanic |
White |
human |
1972 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Intensity-Modulated Radiotherapy, Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0736-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1971 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0737-C18 |
<NA> |
Non-Hispanic |
White |
human |
1989 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0740-C18 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, 3D Conformal, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0801-C56 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0812-C54 |
<NA> |
Hispanic or Latino |
Asian |
human |
1943 |
<NA> |
[GDC] |
[Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0821-C19 |
<NA> |
Non-Hispanic |
Asian |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0835-C20 |
<NA> |
Non-Hispanic |
Asian |
human |
1955 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0838-C18 |
<NA> |
Hispanic or Latino |
White |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0839-C34 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0857-C19 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-0860-C18 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0863-C18 |
<NA> |
Non-Hispanic |
Asian |
human |
1978 |
<NA> |
[GDC] |
[Carcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0867-C18 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1951 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma, Pseudomyxoma peritonei] |
[female] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0878-C18 |
<NA> |
Non-Hispanic |
Asian |
human |
1967 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-0880-C18 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-1097-C18 |
<NA> |
Non-Hispanic |
White |
human |
1962 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-1262-C19 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-1263-C24 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1944 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-CSHL-1266-C20 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1985 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-1268-C24 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-1269-C18 |
<NA> |
<NA> |
<NA> |
human |
1967 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-CSHL-1270-C18 |
Cancer-Related Death |
<NA> |
<NA> |
human |
1957 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-SANG-0265-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0266-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional, Targeted Molecular Therapy] |
| HCMI.HCM-SANG-0268-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0269-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0270-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-0272-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0273-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0274-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0275-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0276-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0277-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0278-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0280-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0281-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0282-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0283-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0284-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0286-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Targeted Molecular Therapy] |
| HCMI.HCM-SANG-0287-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| HCMI.HCM-SANG-0288-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0289-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0291-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0292-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0293-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0294-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0295-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0296-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0297-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0298-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0299-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0300-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0302-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0303-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0306-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0307-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0308-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0309-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0310-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0311-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0312-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-0313-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0314-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0315-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| HCMI.HCM-SANG-0517-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0518-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0519-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0522-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0523-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0525-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0526-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0527-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0529-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0530-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0532-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-0533-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0534-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0535-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-0536-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0537-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0539-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0541-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Radiation, 2D Conventional] |
| HCMI.HCM-SANG-0542-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0543-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0544-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0545-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0546-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0548-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0549-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-0551-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0778-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-0780-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1081-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-1082-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1083-C16 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1084-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-1085-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-1086-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1087-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1088-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Hormone Therapy] |
| HCMI.HCM-SANG-1089-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1090-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1091-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1092-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1093-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1094-C16 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1299-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1300-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1301-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| HCMI.HCM-SANG-1302-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1304-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| HCMI.HCM-SANG-1305-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1306-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1308-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1309-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1310-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1311-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1312-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy, Radiation, 2D Conventional] |
| HCMI.HCM-SANG-1313-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1314-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1315-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1316-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1317-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1318-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1320-C25 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1321-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1322-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1323-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1325-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1326-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1327-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1328-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1329-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1330-C19 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1332-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1333-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1334-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1335-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1336-C15 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[Chemotherapy] |
| HCMI.HCM-SANG-1337-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| HCMI.HCM-SANG-1338-C20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Chemotherapy, Radiation Therapy, NOS] |
| HCMI.HCM-SANG-1339-C18 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| HCMI.HCM-STAN-0777-C25 |
<NA> |
Non-Hispanic |
White |
human |
1951 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Stereotactic Radiosurgery, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-STAN-0841-C18 |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-STAN-0846-C20 |
<NA> |
Hispanic or Latino |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Stereotactic Radiosurgery, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-STAN-0848-C20 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation, 2D Conventional, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-STAN-0909-C16 |
<NA> |
Non-Hispanic |
<NA> |
human |
1934 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-STAN-0914-C34 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1962 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-STAN-1111-C19 |
<NA> |
<NA> |
<NA> |
human |
1984 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-STAN-1113-C18 |
<NA> |
Non-Hispanic |
White |
human |
1952 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0491-C16 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1950 |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0494-C16 |
<NA> |
<NA> |
Asian |
human |
1952 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0502-C15 |
Cancer-Related Death |
Hispanic or Latino |
White |
human |
1973 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0504-C18 |
<NA> |
Hispanic or Latino |
<NA> |
human |
1958 |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0505-C16 |
<NA> |
Non-Hispanic |
Asian |
human |
1941 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-0671-C18 |
<NA> |
<NA> |
White |
human |
1970 |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[Stage IIIB] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0673-C56 |
<NA> |
Non-Hispanic |
Asian |
human |
1986 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[Stage IIIA2] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0749-C34 |
<NA> |
Non-Hispanic |
White |
human |
1945 |
<NA> |
[GDC] |
[Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-0751-C54 |
<NA> |
<NA> |
<NA> |
human |
1965 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, secretory variant] |
[female] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| HCMI.HCM-WCMC-0753-C54 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-0785-C67 |
<NA> |
<NA> |
White |
human |
1961 |
<NA> |
[GDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[Stage IV] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation, Stereotactic/Gamma Knife/SRS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0786-C34 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1942 |
<NA> |
[GDC] |
[Lepidic adenocarcinoma] |
[male] |
[Stage IIIA] |
[] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-0945-C54 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1957 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-0946-C34 |
<NA> |
<NA> |
White |
human |
1939 |
<NA> |
[GDC] |
[Lepidic adenocarcinoma] |
[female] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-1074-C56 |
<NA> |
Non-Hispanic |
White |
human |
1946 |
<NA> |
[GDC] |
[Mucinous adenocarcinoma] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| HCMI.HCM-WCMC-1280-C54 |
<NA> |
Non-Hispanic |
White |
human |
1953 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[] |
[Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-1285-C54 |
<NA> |
<NA> |
<NA> |
human |
1987 |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[Brachytherapy, NOS, Chemotherapy, Hormone Therapy, Immunotherapy (Including Vaccines), Surgery, NOS, Targeted Molecular Therapy] |
| HCMI.HCM-WCMC-1344-C18 |
<NA> |
Non-Hispanic |
White |
human |
1975 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| MATCH.MATCH-B-B517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-B-B51B |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[mammalian vulva] |
[] |
| MATCH.MATCH-B-B51C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-B-B51L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[adrenal gland] |
[] |
| MATCH.MATCH-B-B51O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-B-B51R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| MATCH.MATCH-B-B51Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-B-B522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-C1-B5SQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-C1-B5ST |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest wall] |
[] |
| MATCH.MATCH-C1-B5SU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-C1-B5SV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-C1-B5SW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-C1-B5SZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-C1-B5T0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-H-B4DL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-H-B4DO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[pleura] |
[] |
| MATCH.MATCH-H-B4DP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[peritoneum] |
[] |
| MATCH.MATCH-H-B4DQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-H-B4DW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-H-B4DX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-H-B4E2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[pleura] |
[] |
| MATCH.MATCH-H-B4E3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-I-B5GZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5H0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-I-B5H1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5H5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-I-B5HB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5HL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-I-B5HN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[paraaortic lymph node] |
[] |
| MATCH.MATCH-I-B5HP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[abdominal wall] |
[] |
| MATCH.MATCH-I-B5HR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[chest wall] |
[] |
| MATCH.MATCH-I-B5HZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5I0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[inguinal lymph node] |
[] |
| MATCH.MATCH-I-B5I1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5I4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[pelvic region of trunk] |
[] |
| MATCH.MATCH-I-B5I5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[uterus] |
[] |
| MATCH.MATCH-I-B5I6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-I-B5IB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-I-B5IG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-N-B5T2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[omentum] |
[] |
| MATCH.MATCH-N-B5T9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[pelvic region of trunk] |
[] |
| MATCH.MATCH-N-B5TD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| MATCH.MATCH-N-B5TF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-P-B5TN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-P-B5TT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-P-B5TU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[retroperitoneal lymph node] |
[] |
| MATCH.MATCH-P-B5TV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-P-B5U6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[mammalian vulva] |
[] |
| MATCH.MATCH-P-B5U9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[thoracic segment of trunk] |
[] |
| MATCH.MATCH-Q-B4LA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Q-B4LC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Q-B4LG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Q-B4LH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Q-B4LI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-Q-B4LJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Q-B4LL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[skin of body] |
[] |
| MATCH.MATCH-Q-B4LN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[pelvic region of trunk] |
[] |
| MATCH.MATCH-Q-B4LR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Q-B4LU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-Q-B4LX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[mediastinal lymph node] |
[] |
| MATCH.MATCH-Q-B4M0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Q-B4M1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[adrenal gland] |
[] |
| MATCH.MATCH-Q-B4M2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Q-B4M8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-R-B507 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B508 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-R-B50A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-R-B50C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-R-B50D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-R-B50E |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50H |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50J |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[peritoneum] |
[] |
| MATCH.MATCH-R-B50M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-R-B50R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[sigmoid colon] |
[] |
| MATCH.MATCH-R-B50T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-R-B50X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-S1-B5KK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-S1-B5KP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-S1-B5KR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-S1-B5KS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-S1-B5KU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-S1-B5LA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[gallbladder] |
[] |
| MATCH.MATCH-S1-B5LG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-U-B5O3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[bone tissue] |
[] |
| MATCH.MATCH-U-B5O5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[abdominal wall] |
[] |
| MATCH.MATCH-U-B5O8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[peritoneum] |
[] |
| MATCH.MATCH-W-B4OP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| MATCH.MATCH-W-B4OT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-W-B4OZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-W-B4PA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-W-B4PC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-W-B4PI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-W-B4PK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[peritoneal cavity] |
[] |
| MATCH.MATCH-W-B4PO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-W-B4PS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Y-B4H9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Y-B4HH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Y-B4HI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[abdominal wall] |
[] |
| MATCH.MATCH-Y-B4HL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdominal wall] |
[] |
| MATCH.MATCH-Y-B4HN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[peritoneum] |
[] |
| MATCH.MATCH-Z1A-B4T4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[retroperitoneal space] |
[] |
| MATCH.MATCH-Z1A-B4T5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4T6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4T8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[ovary] |
[] |
| MATCH.MATCH-Z1A-B4TL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[inguinal part of abdomen] |
[] |
| MATCH.MATCH-Z1A-B4TM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[mesentery] |
[] |
| MATCH.MATCH-Z1A-B4TO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdominal wall] |
[] |
| MATCH.MATCH-Z1A-B4TW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4TY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4TZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4U1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4U2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[neck] |
[] |
| MATCH.MATCH-Z1A-B4U5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1A-B4U6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[pelvic region of trunk] |
[] |
| MATCH.MATCH-Z1A-B4U8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1A-B4U9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1B-B5OU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-Z1B-B5OV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[] |
| MATCH.MATCH-Z1B-B5OZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1B-B5P2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-Z1B-B5P5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-Z1B-B5P6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| MATCH.MATCH-Z1B-B5P8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1B-B5PA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1B-B5PC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1D-B44A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[vagina] |
[] |
| MATCH.MATCH-Z1D-B44F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-Z1D-B44H |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[esophagus] |
[] |
| MATCH.MATCH-Z1D-B44J |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lymph node] |
[] |
| MATCH.MATCH-Z1D-B44K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[vagina] |
[] |
| MATCH.MATCH-Z1D-B44L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1D-B44T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-Z1D-B44U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1D-B453 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| MATCH.MATCH-Z1D-B454 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1D-B455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| MATCH.MATCH-Z1D-B456 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[peritoneal cavity] |
[] |
| MATCH.MATCH-Z1D-B458 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[uterus] |
[] |
| MATCH.MATCH-Z1D-B459 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[vagina] |
[] |
| MATCH.MATCH-Z1I-B4WB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1I-B4WF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1I-B4WG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1I-B4WK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1I-B4WQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| MATCH.MATCH-Z1I-B4WS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1I-B4WT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| MATCH.MATCH-Z1I-B4WV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[liver] |
[] |
| ORGANOID.1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.10 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.11 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[] |
| ORGANOID.12 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.13 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.14 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.15 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.16 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.17 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.18 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.19 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.20 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.21 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[] |
| ORGANOID.22 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.23 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.24 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.25 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.26 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[] |
[] |
| ORGANOID.27 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.28 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.29 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[] |
| ORGANOID.3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.30 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.31 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[Stage IIA] |
[] |
[] |
| ORGANOID.32 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.33 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.34 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.35 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.36 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.37 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.38 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[] |
| ORGANOID.39 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.40 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.41 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.42 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[] |
[] |
| ORGANOID.43 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.44 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[] |
| ORGANOID.45 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| ORGANOID.46 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| ORGANOID.47 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[] |
[] |
| ORGANOID.48 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.49 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.50 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.51 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.52 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[] |
[] |
| ORGANOID.53 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.54 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.55 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.56 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[] |
[] |
| ORGANOID.57 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.58 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.59 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[] |
[] |
| ORGANOID.6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[] |
[] |
| ORGANOID.7 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| ORGANOID.8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| ORGANOID.9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[] |
[] |
| REBC.REBC-AC8L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC8M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC8N |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC8O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC8P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC8Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC8R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC8S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC8T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC8U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC8V |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC8W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC8Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC90 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC91 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC92 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC93 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC94 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC96 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC97 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC99 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9B |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9E |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9G |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9I |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9J |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9N |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AC9W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AC9Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AC9Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACA0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACA1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACA2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACA3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACA4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACA5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACA6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACA7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACA8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACA9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACAU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACAW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACAY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACAZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACB0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACB3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACB4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACB5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACB7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACB9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACBQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACBW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACBZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACC0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACC1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACC2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACC4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACC5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACC6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACC7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACC9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACCE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACCG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACCP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACCW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACCY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACCZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACD1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACD2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACD3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACD4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACD5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACD6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACD7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACD8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACDH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACDK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACDW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACDY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACDZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACE0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACE1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACE3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACE4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACE5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACE6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACE7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACE8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACE9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACED |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACEF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACEL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACES |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACET |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACEX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACEZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACF0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACF1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACF3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACF4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACF6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACF7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACF8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACF9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACFD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACFH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACFI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ACFJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ACFK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ACFM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJ5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADJ6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJ8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJ9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADJC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADJU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADJV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADJY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADJZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADK0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADK2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADK3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADK4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADK5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADK6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADK7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADK8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADK9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADKC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADKI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADKT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADKU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADKW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADKX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADKZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADL1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADL5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADL8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADL9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADLA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADLJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADLN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADLT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADLW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADLX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADLZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADM0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADM2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADM3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADM4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-ADM5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADM7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADM8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADM9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMC |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMD |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADME |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-ADMH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-ADMJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF4Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF4Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF50 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF51 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF52 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF53 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF54 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF55 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF57 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF58 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5B |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5E |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5G |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5H |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5N |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF5S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF5U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF5W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF5X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF5Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF60 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF61 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF63 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF64 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF65 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF66 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF69 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF6E |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6H |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF6I |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF6P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF6Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF6U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF6Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF70 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF72 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF73 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF74 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF76 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF78 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF79 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7A |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7B |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF7F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF7I |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7J |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF7M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF7T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7U |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF7X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF7Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF80 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF81 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF83 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF84 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF86 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF87 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF88 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF89 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8B |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| REBC.REBC-AF8C |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8E |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8G |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8H |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8N |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8O |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8V |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| REBC.REBC-AF8W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8Y |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF8Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF90 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF91 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF92 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-AF93 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| REBC.REBC-YQ-A90D |
<NA> |
<NA> |
<NA> |
human |
1976 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90E |
<NA> |
<NA> |
<NA> |
human |
1969 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90F |
<NA> |
<NA> |
<NA> |
human |
1976 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90G |
<NA> |
<NA> |
<NA> |
human |
1975 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90H |
<NA> |
<NA> |
<NA> |
human |
1975 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90I |
<NA> |
<NA> |
<NA> |
human |
1974 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90J |
<NA> |
<NA> |
<NA> |
human |
1986 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90K |
<NA> |
<NA> |
<NA> |
human |
1979 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90L |
<NA> |
<NA> |
<NA> |
human |
1973 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90M |
<NA> |
<NA> |
<NA> |
human |
1980 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90N |
<NA> |
<NA> |
<NA> |
human |
1976 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| REBC.REBC-YQ-A90O |
<NA> |
<NA> |
<NA> |
human |
1975 |
<NA> |
[GDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4244 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4245 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4249 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4250 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4382 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS, Carcinoma in situ, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4384 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4389 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4390 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4395 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4396 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4397 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4398 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4402 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4403 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4405 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4410 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4415 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4417 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4418 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4422 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-05-4424 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy] |
| TCGA.TCGA-05-4426 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4427 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4430 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4432 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4433 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-4434 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-5420 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-5423 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[] |
| TCGA.TCGA-05-5425 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-05-5428 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-05-5429 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-05-5715 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-06-0209 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Glioblastoma, NOS] |
[male] |
[] |
[brain] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-17-Z011 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z013 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z016 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z017 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z018 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z019 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z020 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z024 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z028 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z029 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z030 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z032 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z033 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z034 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z035 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z036 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z038 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z039 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z042 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z043 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z045 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z048 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z050 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z051 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z052 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z053 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z054 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z056 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z058 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z059 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z060 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z061 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest] |
[] |
| TCGA.TCGA-17-Z062 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest] |
[] |
| TCGA.TCGA-22-1000 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-22-A5C4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IIA] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2A-A8VL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-A8VO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-A8VT |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-2A-A8VV |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-A8VX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-A8W1 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-A8W3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-AAYF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-AAYO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2A-AAYU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2E-A9G8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage III] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-2F-A9KT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basaloid squamous cell carcinoma, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IVA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2H-A9GR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2J-AAB1 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2J-AAB4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Radiation Therapy, NOS] |
| TCGA.TCGA-2J-AAB6 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2J-AAB8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2J-AAB9 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABA |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Radiation, External Beam] |
| TCGA.TCGA-2J-AABF |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2J-AABI |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-2J-AABO |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Radiation Therapy, NOS] |
| TCGA.TCGA-2J-AABR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Intraductal carcinoma, noninfiltrating, NOS] |
[female] |
[Stage 0, Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABU |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2J-AABV |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-2K-A9WE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2L-AAQA |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2L-AAQE |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2L-AAQI |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2L-AAQJ |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage III] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2L-AAQL |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-2L-AAQM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9J1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9J2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9J3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9J5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9J6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9J7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9J8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9J9 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Follicular lymphoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JL |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JN |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage 0a, Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-2Z-A9JS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Lentigo maligna melanoma, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-2Z-A9JT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-35-3615 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-35-4122 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-35-4123 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[] |
| TCGA.TCGA-35-5375 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[] |
| TCGA.TCGA-38-4625 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-38-4626 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-4627 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-38-4628 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-4629 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-4630 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-4631 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-4632 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-6178 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Adult granulosa cell tumor of ovary] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-38-7271 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA, Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Cyberknife, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-38-A44F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-3A-A9I5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9I7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9I9 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9IB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-3A-A9IC |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-3A-A9IH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3A-A9IJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basaloid squamous cell carcinoma, Neuroendocrine carcinoma, NOS] |
[male] |
[Stage IB] |
[pancreas] |
[Biopsy, Excisional, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-3A-A9IL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Melanoma in situ, Neuroendocrine carcinoma, NOS] |
[female] |
[Stage 0, Stage 0a, Stage I] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9IN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[female] |
[Stage IB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-3A-A9IO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[male] |
[] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-3A-A9IR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[female] |
[Stage IB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-3A-A9IS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[male] |
[Stage IB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-3A-A9IU |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9IV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3A-A9IX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IA] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-3A-A9IZ |
Cancer-Related Death |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3A-A9J0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-3B-A9HO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Dedifferentiated liposarcoma, Sarcoma, NOS] |
[male] |
[Stage III] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3E-AAAY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3E-AAAZ |
Non-Cancer Related Death |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3L-AA1B |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-3M-AB46 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-3M-AB47 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3P-A9WA |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Cystadenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIB] |
[ovary] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3X-AAV9 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Cholangiocarcinoma, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[bile duct] |
[Ablation or Embolization, NOS, Chemotherapy, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-3Z-A93Z |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-43-2578 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IA] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-43-8118 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IA, Stage IIA] |
[lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-2655 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Intraductal carcinoma, noninfiltrating, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-2656 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-2657 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-2659 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-2661 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-2662 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-2664 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-2665 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-44-2666 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-2668 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Cyberknife, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-3396 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-44-3398 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-3917 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-3918 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-3919 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-4112 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-5643 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, Intensity-Modulated Radiotherapy] |
| TCGA.TCGA-44-5644 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-5645 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6144 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-6145 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6146 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-6147 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neuroendocrine tumor, NOS, Papillary transitional cell carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6148 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6774 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-44-6775 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-6776 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6777 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-44-6778 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-6779 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-7659 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-7660 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-7661 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I, Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-7662 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-7667 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-7669 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Cyberknife, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-7670 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-7671 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-7672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-8117 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-44-8119 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-8120 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-A479 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-A47A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-A47B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-A47F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-44-A47G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-A4SS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-44-A4SU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4486 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4487 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4488 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-49-4490 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-49-4494 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-4501 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Malignant lymphoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4505 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4506 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4507 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4510 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-4512 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-49-4514 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-6742 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-6743 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Clear cell adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-49-6744 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-49-6745 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-6761 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-6767 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-AAQV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage II] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AAR0 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AAR2 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-49-AAR3 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AAR4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-49-AAR9 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-AARE |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AARN |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AARO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-49-AARQ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-49-AARR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-4A-A93W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-4A-A93X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-4A-A93Y |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-4B-A93V |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-4E-A92E |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-4G-AAZG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Cholangiocarcinoma] |
[male] |
[Stage I, Stage III] |
[bile duct] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-4L-AA1F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-4N-A93T |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-4T-AA8H |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-4Z-AA7M |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-4Z-AA7Q |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5044 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5045 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[chest, lung] |
[Brachytherapy, Low Dose, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5049 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5051 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5055 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5066 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5068 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5072 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5930 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5931 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5932 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA, Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5933 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-50-5935 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS] |
| TCGA.TCGA-50-5936 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-5939 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-50-5941 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-50-5942 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS] |
| TCGA.TCGA-50-5944 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell adenoma, Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-50-5946 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-6590 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-50-6591 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-50-6592 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Internal] |
| TCGA.TCGA-50-6593 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-6594 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-6595 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-6597 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neuroendocrine tumor, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-50-6673 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Internal] |
| TCGA.TCGA-50-7109 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-8457 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-50-8459 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-50-8460 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Internal] |
| TCGA.TCGA-53-7624 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-53-7626 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-53-7813 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-53-A4EZ |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation, Systemic] |
| TCGA.TCGA-55-1592 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-1594 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[] |
| TCGA.TCGA-55-1595 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-1596 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-5899 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6543 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6642 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6712 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6968 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-55-6969 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-55-6970 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-6971 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6972 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6975 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6978 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-6979 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-6980 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6981 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-55-6982 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-6983 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6984 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-6985 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6986 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-6987 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7227 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7281 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7283 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7284 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IA, Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7570 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7573 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7574 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7576 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7724 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7725 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7726 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Sebaceous carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7727 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7728 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7816 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7903 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7907 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7910 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7911 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7913 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-7914 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7994 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-7995 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8085 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8087 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8089 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8090 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA, Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8091 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8092 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8094 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8096 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8097 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8203 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, Squamous cell carcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8204 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8205 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-55-8206 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8207 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8208 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8299 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8301 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8302 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8505 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8506 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8507 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8508 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8510 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8511 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8512 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8513 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8514 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8614 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8615 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8616 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-8619 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IB, Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-8620 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-55-8621 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A48X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A48Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-A48Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A490 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-55-A491 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A492 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Medullary carcinoma, NOS] |
[female] |
[Stage IA, Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A493 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-A494 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-A4DF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-55-A4DG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-55-A57B |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-56-A4BY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, keratinizing, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5B-A90C |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-5L-AAT0 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Lobular carcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5M-AAT4 |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5M-AAT5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type] |
[] |
[] |
[colon] |
[] |
| TCGA.TCGA-5M-AAT6 |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5M-AATA |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type] |
[] |
[] |
[colon] |
[] |
| TCGA.TCGA-5M-AATE |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9JU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9JV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9JW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9JY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9JZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9K4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9K9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9KA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9KC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9KE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5P-A9KF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-5P-A9KH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-5S-A9Q8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-60-2696 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IIA] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-62-8394 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-62-8395 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-8397 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-62-8398 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-62-8399 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-62-8402 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-A46O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-A46P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-A46R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-62-A46S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-62-A46U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-62-A46V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-62-A46Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-A470 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-62-A471 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-62-A472 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-1676 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-64-1677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary carcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-1678 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-64-1679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-64-1680 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-64-1681 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-5774 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-5775 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-64-5778 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-5779 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell adenoma, Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-5781 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-64-5815 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-67-3770 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[] |
| TCGA.TCGA-67-3771 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[] |
| TCGA.TCGA-67-3772 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-67-3773 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-67-3774 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-67-3776 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[] |
| TCGA.TCGA-67-4679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[chest, lung] |
[] |
| TCGA.TCGA-67-6215 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-67-6216 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-67-6217 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-68-8250 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma with mixed subtypes, Squamous cell carcinoma, NOS] |
[male] |
[Stage IA] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7760 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7761 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7763 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7764 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7765 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7973 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7974 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-69-7978 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7979 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-7980 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-8253 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-69-8254 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-8255 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Solid carcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-69-8453 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-69-A59K |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-6D-AA2E |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-71-6725 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-71-8520 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-4658 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-73-4659 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-73-4662 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage I, Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-4666 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-4668 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Invasive micropapillary carcinoma] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-4670 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-73-4675 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-4676 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-73-4677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-73-7498 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-73-7499 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-73-A9RS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-5122 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-5125 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-5126 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-5146 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-5147 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-6203 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-6205 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-6206 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-6207 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-6211 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-6212 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Invasive micropapillary carcinoma] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-75-6214 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-7025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-7027 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-75-7030 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-75-7031 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-77-A5GB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, keratinizing, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7143 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7145 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-78-7146 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7147 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7148 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7149 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7150 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7152 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7153 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7154 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[] |
| TCGA.TCGA-78-7155 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7156 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7158 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7159 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7160 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7161 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7162 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7163 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7166 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-78-7167 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7220 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7535 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7536 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7537 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7539 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-7540 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-7542 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[] |
| TCGA.TCGA-78-7633 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA, Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-8640 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-8648 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-8655 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-78-8660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-78-8662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-80-5607 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-80-5608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-80-5611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Solid carcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-83-5908 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-6562 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-6851 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7701 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-7711 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7713 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7714 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7953 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7954 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-7955 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-8054 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8055 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8056 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8073 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8074 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8075 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-86-8076 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8278 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-86-8279 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-86-8280 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8281 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8358 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8359 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8585 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Solid carcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8668 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8669 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-8671 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-8673 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-8674 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-A456 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-A4D0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-86-A4JF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-86-A4P7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-86-A4P8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-90-7964 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6828 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6829 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6830 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-91-6831 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6835 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6836 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-91-6840 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6847 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-91-6848 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-91-6849 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-7771 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Thymoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-8496 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-8497 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-8499 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-91-A4BC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-91-A4BD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-93-7347 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-93-7348 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-93-8067 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-93-A4JN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-93-A4JO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-93-A4JP |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-93-A4JQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-94-7557 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma with mixed subtypes, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7039 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-95-7043 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7562 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7567 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7944 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7947 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Squamous cell carcinoma, NOS] |
[male] |
[Stage IA, Stage III] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-7948 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Hodgkin lymphoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage I, Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-8039 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-95-8494 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-95-A4VK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Malignant melanoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-95-A4VN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-95-A4VP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-96-7545 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IA] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-7546 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7547 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-7552 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7553 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7554 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7937 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Invasive micropapillary carcinoma] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7938 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-7941 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-8171 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-97-8172 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-8174 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-97-8175 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Solid carcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-8176 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-8177 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-97-8179 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-8547 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-8552 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage I] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4LX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-A4M0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4M1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4M2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-97-A4M3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Basal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4M5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4M6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-97-A4M7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-99-7458 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-99-8025 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-99-8028 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-99-8032 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-99-8033 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-99-AA5R |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A2-A04W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Apocrine adenocarcinoma, Infiltrating duct carcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[breast] |
[Bisphosphonate Therapy, Chemotherapy, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A2-A3KD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[breast] |
[Chemotherapy, Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-A2-A4S0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A3-3306 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3307 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3308 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-A3-3311 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3313 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3316 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-A3-3317 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A3-3319 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3320 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3322 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3323 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3324 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3325 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3326 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3328 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine tumor, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3329 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3331 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3335 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A3-3336 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant lymphoma, non-Hodgkin, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3343 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3346 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A3-3347 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A3-3349 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3351 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-A3-3352 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3357 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3358 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3359 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant melanoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3362 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3363 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-A3-3365 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3367 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3370 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3372 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-A3-3373 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3374 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3376 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3378 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3380 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3382 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-A3-3383 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-3385 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-3387 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A3-A8CQ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-A8OU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-A8OV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-A8OW |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A3-A8OX |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A4-7286 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7287 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A4-7288 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7583 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-A4-7584 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7585 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7732 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7734 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7828 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-7915 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-A4-7996 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A4-7997 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8098 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8310 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8311 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8312 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8515 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8516 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8517 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8518 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-8630 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A48D |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A4ZT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A57E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A5DU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A5XZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A5Y0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A5Y1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant lymphoma, small B lymphocytic, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A4-A6HP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A772 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A4-A7UZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A5-A0G1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0G2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0G3 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0G5 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Clear cell adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A0G9 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GB |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0GD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GE |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A0GG |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A0GH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Endometrioid adenocarcinoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA, Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0GP |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0GW |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A0GX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0R6 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0R7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0R8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A0R9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A0RA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0VO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0VP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A0VQ |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A1OF |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A1OG |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A1OH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-A5-A1OJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A1OK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A2K2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A2K3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A2K4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A5-A2K5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-A5-A2K7 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A3LO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-A5-A3LP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-A5-A7WJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-A5-A7WK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-A5-AB3J |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-A6-2670 |
<NA> |
Non-Hispanic |
White |
human |
1964 |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2671 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-2672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2674 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IV] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-2675 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2676 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS] |
[female] |
[Stage III, Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2678 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2680 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-2681 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS, Squamous cell carcinoma in situ, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-2682 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II, Stage IV] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-2683 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-2684 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-2685 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-2686 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-3807 |
<NA> |
Non-Hispanic |
White |
human |
1956 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-3808 |
<NA> |
Non-Hispanic |
White |
human |
1936 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-3809 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-3810 |
<NA> |
Non-Hispanic |
White |
human |
1947 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-4105 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-4107 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5656 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5657 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5659 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5660 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5661 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-5662 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-5664 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-5665 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-5666 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-5667 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6137 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6138 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6140 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6141 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6142 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-6648 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-6649 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6650 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6651 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6652 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-6653 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6654 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6780 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6781 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-6782 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-A6-A565 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-A566 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-A567 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A6-A56B |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-A6-A5ZU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-A7-A26E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Infiltrating ductular carcinoma, Lobular carcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IA, Stage IIIA] |
[breast] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A7-A3IY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage I] |
[breast] |
[Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-A7-A3J0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Hormone Therapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-A7-A3RF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3488 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-3489 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3492 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3494 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3495 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3496 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3506 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3509 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3510 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3511 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3514 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3516 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage III] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3517 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3518 |
<NA> |
<NA> |
<NA> |
human |
1926 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3519 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3520 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3521 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3522 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3524 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3525 |
<NA> |
<NA> |
<NA> |
human |
1917 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3526 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3527 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3529 |
<NA> |
<NA> |
<NA> |
human |
1929 |
2007 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-AA-3530 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3531 |
<NA> |
<NA> |
<NA> |
human |
1932 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3532 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3534 |
<NA> |
<NA> |
<NA> |
human |
1929 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3538 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3542 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3543 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[colon] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3544 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3548 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3549 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-AA-3552 |
<NA> |
<NA> |
<NA> |
human |
1923 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3553 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3554 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3555 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3556 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma, Plasma cell myeloma] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3558 |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3560 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3561 |
<NA> |
<NA> |
<NA> |
human |
1937 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3562 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Carcinoma in situ, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3655 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3660 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3662 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3663 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3664 |
<NA> |
<NA> |
<NA> |
human |
1931 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3666 |
<NA> |
<NA> |
<NA> |
human |
1937 |
2005 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage III] |
[colon] |
[] |
| TCGA.TCGA-AA-3667 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3672 |
<NA> |
<NA> |
<NA> |
human |
1916 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3673 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3675 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3678 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3679 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3680 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3681 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3684 |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-3685 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3688 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma in situ, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3692 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Carcinoma in situ, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3693 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-3695 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-3696 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3697 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3710 |
<NA> |
<NA> |
<NA> |
human |
1928 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3712 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[colon] |
[] |
| TCGA.TCGA-AA-3713 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3715 |
<NA> |
<NA> |
<NA> |
human |
1929 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenosquamous carcinoma, Complex epithelial neoplasms] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3811 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma with neuroendocrine differentiation] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3812 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3814 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3815 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3818 |
<NA> |
<NA> |
<NA> |
human |
1929 |
2007 |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3819 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3821 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3831 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3833 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3837 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3841 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3842 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3844 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3845 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3846 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3848 |
<NA> |
<NA> |
<NA> |
human |
1927 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3850 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[] |
| TCGA.TCGA-AA-3851 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3852 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3854 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3855 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3856 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3858 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3860 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3861 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3862 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3864 |
<NA> |
<NA> |
<NA> |
human |
1934 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3866 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3867 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-3869 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3870 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3872 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-3875 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3877 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3930 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3939 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3941 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3947 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3949 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3950 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3952 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3955 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3956 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3966 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3967 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3968 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3970 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3971 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3972 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Mycosis fungoides] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3973 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-3975 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3976 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3977 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3979 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3980 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3982 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3984 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-3986 |
<NA> |
<NA> |
<NA> |
human |
1934 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3989 |
<NA> |
<NA> |
<NA> |
human |
1925 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-3994 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A004 |
<NA> |
<NA> |
<NA> |
human |
1933 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00A |
<NA> |
<NA> |
<NA> |
human |
1929 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00E |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00F |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00J |
<NA> |
<NA> |
<NA> |
human |
1929 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00K |
<NA> |
<NA> |
<NA> |
human |
1930 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00L |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00N |
<NA> |
<NA> |
<NA> |
human |
1933 |
2008 |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[colon] |
[] |
| TCGA.TCGA-AA-A00O |
<NA> |
<NA> |
<NA> |
human |
1925 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00R |
<NA> |
<NA> |
<NA> |
human |
1944 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[] |
| TCGA.TCGA-AA-A00U |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A00Z |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS, Lymphoid leukemia, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A010 |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A017 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01C |
<NA> |
<NA> |
<NA> |
human |
1934 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01D |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-A01F |
<NA> |
<NA> |
<NA> |
human |
1937 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01G |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01I |
<NA> |
<NA> |
<NA> |
human |
1933 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01K |
<NA> |
<NA> |
<NA> |
human |
1935 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01P |
<NA> |
<NA> |
<NA> |
human |
1923 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-A01Q |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[colon] |
[] |
| TCGA.TCGA-AA-A01R |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage III] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-A01S |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[colon] |
[] |
| TCGA.TCGA-AA-A01T |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A01V |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[] |
| TCGA.TCGA-AA-A01X |
<NA> |
<NA> |
<NA> |
human |
1924 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-A01Z |
<NA> |
<NA> |
<NA> |
human |
1936 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-A022 |
<NA> |
<NA> |
<NA> |
human |
1917 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[] |
| TCGA.TCGA-AA-A024 |
<NA> |
<NA> |
<NA> |
human |
1924 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A029 |
<NA> |
<NA> |
<NA> |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A02E |
<NA> |
<NA> |
<NA> |
human |
1925 |
2007 |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-A02F |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Carcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-A02H |
<NA> |
<NA> |
<NA> |
human |
1933 |
2007 |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-A02J |
<NA> |
<NA> |
<NA> |
human |
1938 |
2008 |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[] |
| TCGA.TCGA-AA-A02K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AA-A02O |
<NA> |
<NA> |
<NA> |
human |
1923 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[colon] |
[] |
| TCGA.TCGA-AA-A02R |
<NA> |
<NA> |
<NA> |
human |
1922 |
2007 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AA-A02W |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AA-A02Y |
<NA> |
<NA> |
<NA> |
human |
1934 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A03F |
<NA> |
<NA> |
<NA> |
human |
1914 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AA-A03J |
<NA> |
<NA> |
<NA> |
human |
1939 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AC-A3W6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Lobular carcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AC-A8OR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-5900 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6548 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6888 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III, Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-6889 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-6890 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6895 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Basaloid squamous cell carcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6899 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6901 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-6963 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-6964 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-6965 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AD-A5EJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AD-A5EK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-2687 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-2689 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AF-2690 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-2691 |
<NA> |
Non-Hispanic |
White |
human |
1961 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-2692 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-2693 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-3400 |
<NA> |
Non-Hispanic |
White |
human |
1955 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AF-3911 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-3912 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-3913 |
<NA> |
Non-Hispanic |
Black or African American |
human |
1949 |
2009 |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage III, Stage IV] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-3914 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AF-4110 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-5654 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-6136 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-6655 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-6672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-A56K |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AF-A56L |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AF-A56N |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3574 |
<NA> |
<NA> |
<NA> |
human |
1916 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3575 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3578 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3580 |
<NA> |
<NA> |
<NA> |
human |
1940 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3581 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3582 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3583 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3584 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3586 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage III] |
[rectum] |
[] |
| TCGA.TCGA-AG-3587 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-3591 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3592 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3593 |
<NA> |
<NA> |
<NA> |
human |
1935 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3594 |
<NA> |
<NA> |
<NA> |
human |
1930 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3598 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3599 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3600 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3601 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[] |
| TCGA.TCGA-AG-3602 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[] |
| TCGA.TCGA-AG-3605 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[rectum] |
[] |
| TCGA.TCGA-AG-3608 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3609 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3611 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3612 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[rectum] |
[] |
| TCGA.TCGA-AG-3728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3731 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-3742 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-3878 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-3881 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3883 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-3885 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3887 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-3890 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3891 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3892 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3893 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3894 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-3896 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-3898 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3901 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3902 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3906 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3909 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-3999 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-4001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-4005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-4007 |
<NA> |
<NA> |
<NA> |
human |
1920 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[] |
| TCGA.TCGA-AG-4008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-4009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-4015 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[] |
| TCGA.TCGA-AG-4021 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-4022 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A002 |
<NA> |
<NA> |
<NA> |
human |
1974 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-A008 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-A00C |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A00H |
<NA> |
<NA> |
<NA> |
human |
1933 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-A00Y |
<NA> |
<NA> |
<NA> |
human |
1940 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-A011 |
<NA> |
<NA> |
<NA> |
human |
1929 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-A014 |
<NA> |
<NA> |
<NA> |
human |
1923 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AG-A015 |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-A016 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-A01J |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[] |
| TCGA.TCGA-AG-A01L |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A01N |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-A01W |
<NA> |
<NA> |
<NA> |
human |
1937 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A01Y |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A020 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[female] |
[Stage III] |
[rectum] |
[Chemotherapy] |
| TCGA.TCGA-AG-A023 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AG-A025 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-A026 |
<NA> |
<NA> |
<NA> |
human |
1940 |
2006 |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[rectum] |
[] |
| TCGA.TCGA-AG-A02G |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-A02N |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AG-A02X |
<NA> |
<NA> |
<NA> |
human |
1930 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[] |
| TCGA.TCGA-AG-A032 |
<NA> |
<NA> |
<NA> |
human |
1939 |
<NA> |
[CDS, GDC, IDC, PDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AG-A036 |
<NA> |
<NA> |
<NA> |
human |
1931 |
<NA> |
[GDC, IDC, PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[rectum] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-AH-6544 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AH-6547 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AH-6549 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AH-6643 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AH-6644 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AH-6897 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AH-6903 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AJ-A23M |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AJ-A23N |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-AJ-A23O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A2QK |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A2QL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A2QM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AJ-A2QN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A2QO |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3BD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Low grade serous carcinoma] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-AJ-A3BF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Low grade serous carcinoma] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AJ-A3BG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AJ-A3BH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AJ-A3BI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AJ-A3BK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3EJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A3EK |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3EL |
<NA> |
<NA> |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3EM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3I9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AJ-A3IA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3NC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3NE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3NF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3NG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3NH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3OJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3OK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A3OL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A3QS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, NOS] |
| TCGA.TCGA-AJ-A3TW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-AJ-A4ZG |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, NOS] |
| TCGA.TCGA-AJ-A5DV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A5DW |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AJ-A6NU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A8CT |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A8CV |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AJ-A8CW |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AK-3425 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3426 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3427 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3428 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3429 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3430 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-AK-3431 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3433 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3434 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-AK-3436 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AK-3440 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3443 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-AK-3444 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-AK-3445 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3447 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-AK-3450 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3451 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3453 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3454 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary carcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3455 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3456 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-AK-3458 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-AK-3460 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3461 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AK-3465 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-AL-3466 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AL-3467 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AL-3468 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Chronic myeloid leukemia, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AL-3471 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AL-3472 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AL-3473 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AL-7173 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AL-A5DJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AM-5820 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[] |
| TCGA.TCGA-AM-5821 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-AP-A051 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A052 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A053 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A054 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A056 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A059 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-AP-A05A |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, NOS, Hormone Therapy, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A05D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A05H |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A05J |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A05N |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A05O |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AP-A05P |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A0L8 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0L9 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A0LE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS, Intraductal carcinoma, noninfiltrating, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A0LH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LI |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A0LJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LM |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A0LN |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AP-A0LP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AP-A0LQ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A0LS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A0LT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A0LV |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1DH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1DK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A1DM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A1DO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1DP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1DQ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1DR |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A1DV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1E0 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A1E1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AP-A1E3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A1E4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AP-A3K1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AP-A5FX |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma with mixed subtypes, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AQ-A54O |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[Stage IIA] |
[breast] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AS-3777 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AS-3778 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AT-A5NU |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AU-3779 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AU-6004 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[] |
| TCGA.TCGA-AW-A1PO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A05S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A05T |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A05U |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A05W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A05Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A05Z |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A060 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A062 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A063 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A064 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A06B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A06D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-AX-A06F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A06H |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A06J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A06L |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A0IS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AX-A0IU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A0IW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A0IZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A0J0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A0J1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1C4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Combination, Surgery, Open] |
| TCGA.TCGA-AX-A1C5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-AX-A1C7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1C8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A1C9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A1CA |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1CC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1CE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-AX-A1CF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1CI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1CJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-AX-A1CK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A1CN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Combination, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-AX-A1CP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-AX-A1CR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Papillary carcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2H2 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2H4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2H5 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2H7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2H8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2HA |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2HC |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2HD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2HF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-AX-A2HG |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-AX-A2HH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2HJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-AX-A2HK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2IN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A2IO |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-AX-A3FS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3FT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3FV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3FW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3FX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3FZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G4 |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3G9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3GB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AX-A3GI |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-AY-4070 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AY-4071 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-5543 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-6196 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-AY-6197 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-6386 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-A54L |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AY-A69D |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-A71X |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AY-A8YK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4308 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4313 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage I, Stage IA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4315 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4323 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4614 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4615 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AZ-4616 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4681 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4682 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-4684 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AZ-5403 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AZ-5407 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6598 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6599 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6600 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6601 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-AZ-6603 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6605 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6606 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6607 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-AZ-6608 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Hodgkin lymphoma, NOS] |
[female] |
[Stage IIIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4688 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4690 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4691 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4693 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4694 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4696 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4697 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4698 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4699 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4700 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4701 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4703 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4706 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4707 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IB, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4710 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4712 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4713 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4714 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4718 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4810 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4811 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4813 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4814 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4815 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Pituitary adenoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4816 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-B0-4817 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4818 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-B0-4819 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4821 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4822 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-B0-4823 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4824 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4827 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4828 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4833 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4834 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4836 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4837 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4838 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4839 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-4841 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4842 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-4843 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-4844 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4845 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4846 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-4847 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-4848 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-B0-4849 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-B0-4852 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-B0-4945 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5075 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-5077 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5080 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5081 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5083 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5084 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, Cyberknife, Surgery, NOS] |
| TCGA.TCGA-B0-5085 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-5088 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant melanoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I, Stage IIIB] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5092 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-B0-5094 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5095 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-5096 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-5097 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5098 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5099 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B0-5100 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5102 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5104 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5106 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B0-5107 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5108 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5109 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5110 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5113 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5115 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5116 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5117 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5119 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5120 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5121 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5399 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5400 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5402 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5690 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5691 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5692 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5693 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5694 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, clear cell type] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Cyberknife, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5695 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5696 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5697 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5698 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage I, Stage IB] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5699 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5700 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5701 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5702 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5703 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5705 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5706 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5707 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5709 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5710 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5711 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5712 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B0-5713 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B0-5812 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-5398 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-7332 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-A47M |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B1-A47N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-A47O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B1-A654 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-A655 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-A656 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B1-A657 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B2-3923 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-3924 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-4098 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B2-4099 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-4101 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-4102 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-5633 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-5635 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-5636 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-5639 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B2-5641 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B2-A4SR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B3-3925 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B3-3926 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B3-4103 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B3-4104 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-B3-8121 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B3-A6W5 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B4-5377 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5378 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5832 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5834 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5835 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5836 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5838 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5843 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B4-5844 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B5-A0JN |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Intraductal carcinoma, noninfiltrating, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A0JR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0JS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0JT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0JU |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0JV |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A0JX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0JY |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Carcinoma, NOS, Endometrioid adenocarcinoma, NOS, Epithelial tumor, benign] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A0JZ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A0K0 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0K1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A0K2 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0K3 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A0K4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0K6 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0K7 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A0K8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0K9 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A0KB |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A11E |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11F |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A11G |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A11H |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A11I |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A11J |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A11L |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Combination, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A11M |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A11N |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11O |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A11P |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11Q |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11R |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11S |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A11U |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11V |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11W |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11X |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Carcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open, Targeted Molecular Therapy] |
| TCGA.TCGA-B5-A11Y |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Endometrioid adenocarcinoma, secretory variant] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A11Z |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A121 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A1MR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-B5-A1MS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-B5-A1MU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A1MV |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A1MW |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A1MX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A1MY |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A1MZ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-B5-A1N2 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A3F9 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A3FA |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A3FB |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A3FC |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-B5-A3FD |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-B5-A3FH |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A3S1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-B5-A5OC |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-B5-A5OD |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-B5-A5OE |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B6-A0I8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[female] |
[Stage II, Stage X] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B6-A0IC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage X] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B7-5816 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B7-5818 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B7-A5TI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-B7-A5TJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B7-A5TK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-B7-A5TN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4143 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-B8-4146 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4148 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4151 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4153 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-4154 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4619 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4620 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-4621 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-4622 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-5158 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5159 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5162 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5163 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5164 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-B8-5165 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5545 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5546 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B8-5549 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5550 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-5551 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B8-5552 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-5553 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B8-A54H |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-A54K |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B8-A7U6 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B8-A8YJ |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-4113 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B9-4114 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS] |
| TCGA.TCGA-B9-4115 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B9-4116 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-B9-4117 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-B9-4617 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-B9-5155 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-5156 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-7268 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-A44B |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B9-A5W7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-B9-A5W8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-A5W9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-A69E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-A8YH |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-B9-A8YI |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BA-6871 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-BA-A4IG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BC-A112 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BG-A0LW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0LX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0M0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0M2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0M3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0M4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0M6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Basal cell carcinoma, NOS, Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Infiltrating duct mixed with other types of carcinoma, Serous carcinoma, NOS] |
[female] |
[Stage I, Stage IA, Stage IIIC2] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0M7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0M8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA, Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0M9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0MA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0MC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0MG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0MH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-BG-A0MI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0MK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0MO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0MQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0MS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0MT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0MU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-BG-A0RY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0VT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A0VV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0VW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0VX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-BG-A0VZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0W1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0W2 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0YU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A0YV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Malignant lymphoma, small B lymphocytic, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A186 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A187 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A18A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A18B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A18C |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A220 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA, Stage IV] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A221 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A222 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BG-A2AD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A2AE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-BG-A2L7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-BG-A3EW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage III] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-BG-A3PP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-BH-A0EA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage I, Stage IIA] |
[breast] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BH-A0HL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[breast] |
[Chemotherapy, Hormone Therapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BJ-A0YZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0Z0 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0Z3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0Z5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0ZA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0ZB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0ZC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0ZE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A0ZJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A18Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-BJ-A18Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-BJ-A190 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-BJ-A192 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Oxyphilic adenocarcinoma] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A28Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-BJ-A290 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary carcinoma, columnar cell] |
[male] |
[Stage III, Stage IIIA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A291 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage 0a, Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A2N7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-BJ-A2N8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A2N9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A2NA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A2P4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A3EZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A3F0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A3PR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A3PT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-BJ-A3PU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BJ-A45C |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic] |
| TCGA.TCGA-BJ-A45E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BJ-A45F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-BJ-A45H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-BJ-A4O8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-BK-A0C9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BK-A0CA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BK-A0CB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BK-A0CC |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BK-A139 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-BK-A13B |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BK-A13C |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BK-A26L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-BK-A4ZD |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-BK-A56F |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-BK-A6W3 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BK-A6W4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, NOS] |
| TCGA.TCGA-BM-6198 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4158 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4159 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Surgery, NOS] |
| TCGA.TCGA-BP-4160 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4161 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4162 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4163 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4164 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4165 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4166 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4167 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4169 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4170 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4173 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-4174 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-4176 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4177 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4325 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4326 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4327 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4329 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4330 |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4331 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4332 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4334 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4335 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4337 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4338 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4340 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4341 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4342 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4343 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4344 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4345 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4346 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4347 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4349 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4351 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4352 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4353 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant lymphoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4354 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4355 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4756 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4758 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4759 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4760 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4761 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4762 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4763 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4765 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4766 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4768 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female, male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4769 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4770 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4771 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4774 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4775 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4776 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4777 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4781 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4782 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4784 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4787 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4789 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4790 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4795 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4797 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4798 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[kidney] |
[] |
| TCGA.TCGA-BP-4799 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Follicular lymphoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-4801 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4803 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4804 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4807 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary carcinoma, follicular variant, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4959 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4960 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-4961 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4962 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-4963 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4964 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4965 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Follicular lymphoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4967 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4968 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4969 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4970 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4971 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4972 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4973 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4974 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4975 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4976 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4977 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4981 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4982 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4983 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4985 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-4986 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Mucinous adenocarcinoma, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4987 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4988 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4989 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-4991 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4992 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4993 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4994 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4995 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-4998 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-4999 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5000 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5001 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5004 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5006 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5007 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-5008 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5009 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Hairy cell leukemia, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-5010 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-5168 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenosquamous carcinoma, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5169 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5170 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5173 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5174 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5175 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5176 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5177 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5178 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-5180 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5181 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5182 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5183 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-5184 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5185 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-5186 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5187 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5189 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BP-5190 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5191 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5192 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5194 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5195 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5196 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BP-5198 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BP-5199 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Combined small cell carcinoma, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BP-5200 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BP-5201 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant melanoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BP-5202 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5875 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5876 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5877 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BQ-5878 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-5879 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-5880 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BQ-5881 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5882 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BQ-5883 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5884 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5885 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5886 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-5887 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5888 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating ductular carcinoma, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-5889 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-5890 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5891 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-5892 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-5893 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BQ-5894 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7044 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7045 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7046 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-7048 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-7049 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Malignant melanoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-7050 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7051 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7053 |
<NA> |
Hispanic or Latino |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7055 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BQ-7056 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant fibrous histiocytoma, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-7058 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-BQ-7059 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7060 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7061 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BQ-7062 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-BR-4183 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4184 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4187 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4188 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4191 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4201 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4253 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4255 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4256 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4257 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4267 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4279 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4280 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage III] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-4292 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4294 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4357 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4361 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[] |
| TCGA.TCGA-BR-4362 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4363 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4366 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4367 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4368 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-BR-4369 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4370 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-4371 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[stomach] |
[] |
| TCGA.TCGA-BR-6452 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6453 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6454 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[] |
| TCGA.TCGA-BR-6455 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-6456 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6457 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6458 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-6563 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6564 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6565 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6566 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6705 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6706 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-6707 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-6709 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6710 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6801 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6802 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-6803 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-6852 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7196 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-7197 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7703 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7704 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7707 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7715 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7716 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7717 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7722 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7723 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-7851 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7901 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-7957 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7958 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-7959 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8058 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8059 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8060 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8077 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8078 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8080 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8081 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8284 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8285 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8286 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8289 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8291 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8295 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8296 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8297 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8360 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8361 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8362 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8363 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8364 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8365 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8366 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8367 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8368 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8369 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8370 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8371 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8372 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8373 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8380 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8381 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8382 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8384 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8483 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8484 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8485 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8486 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8487 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8588 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8589 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8590 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-8591 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8592 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8676 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8678 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8680 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8682 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8683 |
Non-Cancer Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8686 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8687 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-8690 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A44T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-A44U |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A452 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A453 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4CQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-A4CR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4CS |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4IU |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4IV |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-A4IY |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4IZ |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J1 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J4 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J5 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J7 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4J9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4PD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4PE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4PF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4QI |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BR-A4QL |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-BR-A4QM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BS-A0T9 |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TA |
<NA> |
Hispanic or Latino |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Combination, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TC |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TD |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TE |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-BS-A0TI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0TJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Combination, Surgery, Open] |
| TCGA.TCGA-BS-A0U5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0U7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0U8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Combination, Surgery, Open] |
| TCGA.TCGA-BS-A0U9 |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UF |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UL |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UT |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0UV |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0V4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0V6 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0V7 |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0V8 |
<NA> |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0VI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BS-A0WQ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-BT-A20T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BT-A20W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-BT-A3PJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage III, Stage IIIA] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-BW-A5NQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-C5-A1M9 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A1ME |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A1MJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS] |
| TCGA.TCGA-C5-A2LS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A2M1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A2M2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A3HF |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation, Combination, Radiation Therapy, NOS] |
| TCGA.TCGA-C5-A7CM |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal] |
| TCGA.TCGA-C5-A7X8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-C5-A8XJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[female] |
[Stage IB] |
[uterine cervix] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-C8-A12X |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-C8-A1HL |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-C8-A8HQ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CA-5254 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-5255 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CA-5256 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-5796 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-5797 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-6715 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-6716 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-6717 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CA-6718 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CA-6719 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-5798 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-5799 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-5800 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-5801 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-5802 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-5803 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-5804 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-5813 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8524 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8525 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-8526 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-8527 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8528 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-8529 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-8530 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-8531 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-8532 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8533 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8534 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-8535 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-8536 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-A486 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-A487 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CD-A489 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-A48A |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-A48C |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-A4MG |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-A4MH |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-CD-A4MI |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CD-A4MJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CE-A13K |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A27D |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A3MD |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A3ME |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A481 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Chemotherapy, I-131 Radiation Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A482 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A483 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A484 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CE-A485 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4300 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[] |
| TCGA.TCGA-CG-4301 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4304 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[] |
| TCGA.TCGA-CG-4305 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4306 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4436 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4437 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4438 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4440 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4441 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[] |
| TCGA.TCGA-CG-4442 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[] |
| TCGA.TCGA-CG-4443 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[] |
| TCGA.TCGA-CG-4444 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4449 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4455 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4460 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4462 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy] |
| TCGA.TCGA-CG-4466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4469 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy] |
| TCGA.TCGA-CG-4472 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4474 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-4475 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4476 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-4477 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5716 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5717 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5718 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5719 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-5720 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[] |
| TCGA.TCGA-CG-5721 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5722 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-5723 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5724 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5725 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CG-5726 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[] |
| TCGA.TCGA-CG-5727 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5728 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[] |
| TCGA.TCGA-CG-5730 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[] |
| TCGA.TCGA-CG-5732 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5733 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CG-5734 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[] |
| TCGA.TCGA-CH-5737 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5738 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5739 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5740 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5741 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5743 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5744 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5745 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5746 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5748 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5750 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5751 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Ancillary Treatment, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5752 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5753 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Malignant lymphoma, non-Hodgkin, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5754 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5761 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5762 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5763 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[Stage IA] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5764 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[Stage III] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5765 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5766 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5767 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5768 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5769 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5771 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5772 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5788 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5789 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5790 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5791 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CH-5792 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-CH-5794 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CI-6619 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[rectum] |
[] |
| TCGA.TCGA-CI-6620 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CI-6621 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CI-6622 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CI-6623 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CI-6624 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4634 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4635 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4636 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basaloid squamous cell carcinoma, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4637 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4638 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4639 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4640 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4641 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4642 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant lymphoma, non-Hodgkin, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4643 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4644 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4868 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4869 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4870 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4871 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4872 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4873 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4874 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4875 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4876 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4878 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4881 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4882 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4884 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4885 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4886 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4887 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4888 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4889 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4890 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4891 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Hodgkin lymphoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-4892 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4893 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4894 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant melanoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4895 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4897 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4899 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4900 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4901 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4902 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4903 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4904 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine tumor, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4905 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4907 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4908 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4912 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4913 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-4916 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4918 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-4920 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-4923 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female, male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-5671 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-5672 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-5675 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-5676 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-5677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-5678 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CJ-5679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-5680 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-5681 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-5682 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-CJ-5683 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-5684 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CJ-5686 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-5689 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-6027 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-6028 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CJ-6030 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-6031 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CJ-6032 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CJ-6033 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CK-4947 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CK-4948 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-4950 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-4951 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CK-4952 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-5912 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-5913 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-5914 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| TCGA.TCGA-CK-5915 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[] |
| TCGA.TCGA-CK-5916 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CK-6746 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-6747 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-6748 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CK-6751 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CL-4957 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CL-5917 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CL-5918 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4743 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4744 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4746 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4747 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CM-4748 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4750 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4751 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-4752 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5341 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5344 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5348 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5349 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5860 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5861 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CM-5862 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CM-5863 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5864 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-5868 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6161 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6162 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6163 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6164 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6165 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6166 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6167 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6168 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6169 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6170 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6171 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6172 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6674 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6675 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IVB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CM-6676 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6677 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6678 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CM-6679 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CM-6680 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CN-4727 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS, Squamous cell neoplasms] |
[male] |
[Stage IV, Stage IVA] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CN-6022 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage I, Stage IVA] |
[craniocervical region] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CN-6023 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CN-6024 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CN-6992 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CN-A6V3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVA] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CR-6472 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IVB] |
[craniocervical region] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-CU-A0YN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CU-A0YO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CU-A0YR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CU-A3KJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma in situ, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage 0is, Stage I, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CU-A72E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Merkel cell carcinoma, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIA, Stage IV] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CW-5580 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Radiation, External Beam] |
| TCGA.TCGA-CW-5581 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CW-5583 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CW-5584 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CW-5585 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Targeted Molecular Therapy] |
| TCGA.TCGA-CW-5587 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CW-5588 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CW-5589 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CW-5590 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CW-5591 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CW-6087 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-CW-6088 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CW-6090 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CW-6093 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CW-6096 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CW-6097 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS] |
| TCGA.TCGA-CZ-4853 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-4854 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CZ-4856 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CZ-4857 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CZ-4858 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CZ-4859 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-4860 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-4861 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-4862 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Malignant lymphoma, non-Hodgkin, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CZ-4863 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CZ-4864 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-4865 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Intraductal carcinoma, noninfiltrating, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I, Stage IIIA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-CZ-4866 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5451 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5452 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5453 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5454 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-5455 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Radiation, Stereotactic/Gamma Knife/SRS] |
| TCGA.TCGA-CZ-5456 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-5457 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CZ-5458 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5459 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5460 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS] |
| TCGA.TCGA-CZ-5461 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-5462 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy] |
| TCGA.TCGA-CZ-5463 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5464 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-5465 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5466 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5467 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CZ-5468 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5469 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-CZ-5470 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5982 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5984 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5985 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5986 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5987 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-CZ-5988 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-CZ-5989 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[] |
| TCGA.TCGA-D1-A0ZN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A0ZO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Papillary carcinoma, follicular variant] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A0ZP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A0ZQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A0ZR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A0ZS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A0ZU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Endometrioid adenocarcinoma, secretory variant] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A0ZV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A0ZZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A101 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A102 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A103 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A15V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A15W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A15X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A15Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A160 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A161 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A162 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A163 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A165 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A167 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A168 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A169 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-D1-A16B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A16D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A16E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IV] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16I |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A16J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A16N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A16O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A16Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A174 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A175 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A176 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A177 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-D1-A179 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-D1-A17A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A17B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17C |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A17K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-D1-A17L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A17M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17N |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A17Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A17T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A17U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-D1-A1NS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1NU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A1NW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1NX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1NY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-D1-A1NZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1O0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1O5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A1O7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-D1-A1O8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A2G0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A2G5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A2G6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A2G7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A3DA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A3DG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A3DH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-D1-A3JP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-D1-A3JQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-D3-A2J7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IIIC] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-5537 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-5538 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-5539 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-5540 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-5541 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6529 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-6530 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6531 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6532 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6533 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6534 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6535 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6536 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-6537 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D5-6538 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6539 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6540 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6541 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6898 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6920 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6922 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6923 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6924 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6926 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-D5-6927 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6928 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6929 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6930 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6931 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-6932 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D5-7000 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-5577 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-5578 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-5579 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6518 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6519 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6520 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6521 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6522 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6524 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6525 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6526 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6527 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-D7-6528 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6815 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6817 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-D7-6818 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-6820 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-6822 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-8570 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-8572 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-8573 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-8574 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-D7-8575 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-8576 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-8578 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-8579 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-D7-A4YT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A4YU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A4YV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A4YX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A4YY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-D7-A4Z0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-D7-A6ET |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-A6EV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A6EX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A6EY |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A6EZ |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A6F0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A6F2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A747 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A748 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D7-A74A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-D7-A74B |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A1JS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage IA] |
[breast] |
[Hormone Therapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A1X7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A1XC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A1XV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A27W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[breast] |
[Chemotherapy, Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-D8-A73W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIA] |
[breast] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-D8-A73X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Neoplasm, malignant, Tubular adenocarcinoma] |
[female] |
[Stage IIA] |
[breast] |
[Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-DC-4745 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-4749 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-5337 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-5869 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6154 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6155 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6156 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DC-6157 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6158 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6160 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6681 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6682 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DC-6683 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DD-A3A8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage II] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DD-A4NI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage II] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DD-AADV |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DD-AAE7 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Hepatocellular carcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DD-AAE8 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Chemoembolization, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DE-A0XZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant melanoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II, Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-DE-A0Y2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-DE-A0Y3 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVC] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DE-A3KN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-DE-A4M8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A4M9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A4MA |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A4MB |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A4MC |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-DE-A4MD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-DE-A69J |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A69K |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DE-A7U5 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DF-A2KN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DF-A2KR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-DF-A2KS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-DF-A2KU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-DF-A2KV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-DF-A2KY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-DF-A2KZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-DF-A2L0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-DG-A2KH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DG-A2KK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Radiation, External Beam] |
| TCGA.TCGA-DI-A0WH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DI-A1BU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Brachytherapy, NOS, Chemotherapy, Pharmaceutical Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DI-A1BY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Brachytherapy, NOS, Pharmaceutical Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DI-A1C3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DI-A1NN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-DI-A1NO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-DI-A2QT |
<NA> |
Hispanic or Latino |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC] |
[abdomen, uterus] |
[Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-DI-A2QU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-DI-A2QY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-DJ-A13L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant, Papillary carcinoma, columnar cell] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DJ-A13O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A13P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A13T |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A13U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A13V |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QN |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A1QQ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2PR |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Astrocytoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2PT |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2PU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2PW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2PZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2Q0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2Q1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2Q4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2Q5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2Q6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A2Q7 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A2QC |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UM |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A3US |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DJ-A3UV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant lymphoma, non-Hodgkin, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DJ-A3UW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DJ-A3UX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3UZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3V2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3V3 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3V9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A3VA |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3VD |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A3VE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A3VI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basaloid squamous cell carcinoma, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DJ-A4UL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A4UP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DJ-A4UT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A4V0 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A4V2 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-DJ-A4V5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-DK-A1AA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A1AC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A2I6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A3IN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage IA, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DK-A3IQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Papillary adenocarcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A3IS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A3IT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DK-A3IU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A3IV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A6B0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-A6B6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-AA6L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage II, Stage IV] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-AA71 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-AA74 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage 0is, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-AA75 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DK-AA77 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A0X9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A0XD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A0XF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy] |
| TCGA.TCGA-DM-A1D0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A1D4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A1D6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A1D7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A1D8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[] |
[colon] |
[] |
| TCGA.TCGA-DM-A1D9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A1DA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-DM-A1DB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A1HA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-DM-A1HB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| TCGA.TCGA-DM-A280 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A282 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A285 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DM-A288 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A28A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-DM-A28C |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A28E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A28F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| TCGA.TCGA-DM-A28G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A28H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DM-A28K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DM-A28M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[] |
| TCGA.TCGA-DO-A1K0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation, Radioisotope, Surgery, NOS] |
| TCGA.TCGA-DO-A2HM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DS-A7WH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-DT-5265 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5565 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-DV-5566 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5567 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DV-5568 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Hemangioma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5569 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5573 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5574 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DV-5575 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-5576 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Neuroendocrine carcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-A4VX |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-DV-A4VZ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DV-A4W0 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DW-5560 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-5561 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7834 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7836 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant melanoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7837 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7838 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DW-7839 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7840 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7841 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7842 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DW-7963 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DX-A7EL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Leiomyosarcoma, NOS, Sarcoma, NOS] |
[female] |
[] |
[] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DX-A7ET |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Sarcoma, NOS, Undifferentiated sarcoma] |
[male] |
[] |
[] |
[] |
| TCGA.TCGA-DX-A7EU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Myxofibrosarcoma, Sarcoma, NOS] |
[female] |
[] |
[] |
[] |
| TCGA.TCGA-DY-A0XA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-DY-A1DC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DY-A1DD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[] |
| TCGA.TCGA-DY-A1DE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-DY-A1DF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[] |
| TCGA.TCGA-DY-A1DG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[rectum] |
[Surgery, NOS] |
| TCGA.TCGA-DY-A1H8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[rectum] |
[] |
| TCGA.TCGA-DZ-6131 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-DZ-6132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-DZ-6133 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-DZ-6134 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-DZ-6135 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-E3-A3E0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E3-A3E1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E3-A3E3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-E3-A3E5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-E6-A1LX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-E6-A1LZ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-E6-A1M0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-E6-A2P8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IV] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-E6-A2P9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-E6-A8L9 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-E7-A541 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-E8-A242 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A2EA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A2JQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-E8-A3X7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-E8-A413 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A414 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A415 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A416 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A417 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A418 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A419 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-E8-A432 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-E8-A433 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A434 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A436 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A437 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A438 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A44K |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-E8-A44M |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-E9-A54X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-E9-A5UO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-E9-A5UP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-EA-A4BA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EA-A556 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EC-A1NJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EC-A1QX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EC-A24G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-EE-A184 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IB] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EE-A20H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Malignant melanoma, NOS, Nevi and melanomas, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EE-A2MC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS, Nevi and melanomas] |
[male] |
[Stage I] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EE-A3JD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage III] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EF-5830 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EF-5831 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6506 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6507 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6508 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6509 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EI-6510 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[female] |
[] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6511 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6512 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6513 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6514 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6881 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma in tubulovillous adenoma, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6882 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6883 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIC] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6884 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-6885 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IV] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EI-6917 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIIA] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-7002 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EI-7004 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[] |
[rectum] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5494 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5495 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5496 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5497 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5498 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5499 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5501 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5502 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5503 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5504 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5505 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5506 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5507 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5508 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5509 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5510 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5511 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5512 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5514 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5515 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5516 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5517 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5518 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5519 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5521 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5522 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5524 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5525 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5526 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5527 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5530 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5531 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5532 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-5542 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Malignant melanoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7115 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7123 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7125 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7218 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7312 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7314 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7315 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7317 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7318 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7321 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7325 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7327 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7328 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7330 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[] |
| TCGA.TCGA-EJ-7331 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7781 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7782 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7783 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7784 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7785 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7786 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7788 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7789 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7791 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7792 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7793 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7794 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-7797 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-8468 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-8469 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-8470 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-8472 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-8474 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EJ-A46H |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A46I |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65B |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65E |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65F |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65G |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A65J |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EJ-A65M |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A6RA |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A6RC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A7NN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A8FN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A8FO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A8FP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A8FS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-A8FU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-AB20 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EJ-AB27 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EK-A2GZ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EK-A2RL |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EK-A3GK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EK-A3GM |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3CL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3CM |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3CN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3CO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3CR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3CS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3CT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3CU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3CV |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3CW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3CX |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3CY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3CZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3D0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3D1 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3D4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3D5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenoid cystic carcinoma, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3D6 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GO |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3GP |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3GR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GS |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GU |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Surgery, NOS] |
| TCGA.TCGA-EL-A3GV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GW |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-EL-A3GY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3GZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3H1 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3H2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3H3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3H4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3H5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3H7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3H8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3MW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3MX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVC] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-EL-A3MY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVC] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3MZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-EL-A3N2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3N3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Leiomyosarcoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3T0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3T1 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3T2 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-EL-A3T3 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3T6 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3T7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3T8 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3T9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3TA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3TB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZG |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A3ZO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy] |
| TCGA.TCGA-EL-A3ZP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A3ZT |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EL-A4JV |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4JW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4JX |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4JZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4K0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4K1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4K2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4K4 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4K6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-EL-A4K7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4K9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4KD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4KG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EL-A4KH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EL-A4KI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-EM-A1CS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A1CT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A1CU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A1CV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A22I |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A22K |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-EM-A22M |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A22O |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic] |
| TCGA.TCGA-EM-A22P |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A2OX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A2OZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A2P0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A2P1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A2P3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3AK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3AN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3AO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3AQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Malignant melanoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3AR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3FJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3FK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3FM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3FO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3FQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3FR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3O3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3O7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3SU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A3SX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A3SZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EM-A4FF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-EM-A4FM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Intensity-Modulated Radiotherapy, Radiation, Systemic] |
| TCGA.TCGA-EM-A4FN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A4FO |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A4FR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-EM-A4FV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EO-A1Y5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A1Y7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EO-A1Y8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A22R |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-EO-A22S |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-EO-A22T |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-EO-A22U |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A22X |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A22Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-EO-A2CG |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A2CH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-EO-A3AS |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EO-A3AU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EO-A3AV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3AY |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EO-A3AZ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3B0 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EO-A3B1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3KU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3KW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3KX |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-EO-A3L0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-EQ-5647 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EQ-8122 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-EQ-A4SO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ER-A198 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[] |
[skin of body] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ES-A2HS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage I] |
[liver] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ET-A25J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A25K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A25M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A25N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A25O |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A25P |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A2MX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A2MY |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A2MZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A2N0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A2N1 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A39J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A39K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ET-A39L |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-ET-A39M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A39N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A39P |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A39R |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A39S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3BN |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3BP |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A3BQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3BS |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A3BU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3BV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Neuroendocrine tumor, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ET-A3BW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3BX |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3DO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ET-A3DP |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3DR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3DS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3DT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A3DU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-ET-A40S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-ET-A40T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EU-5904 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EU-5905 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EU-5906 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EU-5907 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-EV-5901 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EV-5902 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EV-5903 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-EW-A2FW |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Intraductal papillary adenocarcinoma with invasion, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[breast] |
[Chemotherapy, Hormone Therapy, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-EX-A1H6 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-EX-A449 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Low cumulative sun damage melanoma, Neoplasm, malignant] |
[female] |
[Stage II, Stage IVB] |
[uterine cervix] |
[Biopsy, Excisional, Chemotherapy, Hysterectomy, NOS, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-EY-A1G7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A1G8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EY-A1GC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GD |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GF |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EY-A1GJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-EY-A1GM |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A1GO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A1GP |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A1GR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EY-A1GS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-EY-A1GT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Brachytherapy, High Dose, Pharmaceutical Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A1GW |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-EY-A1GX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A1H0 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-EY-A210 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A212 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Low grade serous carcinoma] |
[female] |
[Stage IIIC1] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A214 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Intraductal carcinoma, noninfiltrating, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A215 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Chondrosarcoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A2OM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A2ON |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A2OO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A2OP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A2OQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A3L3 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A3QX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A4KR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A547 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IA, Stage IIA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A548 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A549 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-EY-A54A |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A5W2 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-EY-A72D |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenoid basal carcinoma, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-F1-6177 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F1-6874 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F1-6875 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F1-A448 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-F1-A72C |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F2-6879 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-F2-6880 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-F2-7273 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-F2-7276 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-F2-A44G |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-F2-A44H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-F2-A7TX |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-F2-A8YN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-F4-6459 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6460 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F4-6461 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F4-6463 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6569 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6570 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6703 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6704 |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIC] |
[colon] |
[] |
| TCGA.TCGA-F4-6805 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6806 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-F4-6807 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6808 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6809 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6854 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6855 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F4-6856 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage I] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6464 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6465 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6571 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-F5-6702 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F5-6810 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[rectum] |
[] |
| TCGA.TCGA-F5-6811 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6812 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6813 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F5-6814 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6861 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F5-6863 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F5-6864 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[rectum] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-F9-A4JJ |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-F9-A7Q0 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F9-A7VF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F9-A8NY |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-F9-A97G |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FB-A4P5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-A4P6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FB-A545 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FB-A5VM |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FB-A78T |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-A7DR |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Total Pancreatectomy] |
| TCGA.TCGA-FB-AAPP |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FB-AAPQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAPS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAPU |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAPY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-FB-AAPZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FB-AAQ0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAQ1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAQ2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FB-AAQ3 |
Surgical Complication |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FB-AAQ6 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Transitional cell carcinoma, NOS] |
[male] |
[Stage IA, Stage II] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FC-7708 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FC-7961 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FC-A4JI |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-FC-A5OB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-FC-A66V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FC-A6HD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FC-A8O0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FD-A3B6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FD-A3B7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A3NA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage II, Stage IIA] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A3SN |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A3SQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A3SR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A43P |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IIA] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A43Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A5BR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FD-A5BS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[urinary bladder] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A5BX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIA, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A5BY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A5C0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A62P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A6TA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A6TD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A6TE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIA, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A6TG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FD-A6TI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A230 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A231 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS] |
| TCGA.TCGA-FE-A232 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope] |
| TCGA.TCGA-FE-A233 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A234 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A235 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS] |
| TCGA.TCGA-FE-A236 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS] |
| TCGA.TCGA-FE-A237 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A238 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS] |
| TCGA.TCGA-FE-A239 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FE-A23A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Radioisotope, Radiation Therapy, NOS] |
| TCGA.TCGA-FE-A3PB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FE-A3PC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FI-A2CX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basaloid squamous cell carcinoma, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-FI-A2CY |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Cystic, mucinous and serous neoplasms, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2D0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2D2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2D4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2D5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2D6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2EU |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2EW |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2EX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2EY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2F4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Pheochromocytoma, NOS] |
[female] |
[Stage IC] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2F8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A2F9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Implants, Surgery, Open] |
| TCGA.TCGA-FI-A3PV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FI-A3PX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC2] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-FK-A3SB |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-FK-A3SD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating ductular carcinoma, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-FK-A3SE |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FK-A3SG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FK-A3SH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FK-A4UB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FL-A1YF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YG |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YM |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YU |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A1YV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FL-A3WE |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[] |
[] |
[uterus] |
[] |
| TCGA.TCGA-FP-7735 |
Non-Cancer Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FP-7829 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-FP-7916 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-FP-7998 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-FP-8099 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FP-8209 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FP-8210 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-FP-8211 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-FP-8631 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FP-A4BE |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-FP-A4BF |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FP-A8CX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Seminoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FP-A9TM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-FT-A61P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FU-A3EO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal] |
| TCGA.TCGA-FU-A40J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-FU-A57G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FU-A770 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FV-A3I1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[female] |
[Stage II] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FY-A2QD |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[] |
[thyroid gland] |
[] |
| TCGA.TCGA-FY-A3BL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A3I4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A3NM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A3NN |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[] |
| TCGA.TCGA-FY-A3ON |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A3R6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A3R7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A3R8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A3RA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A3TY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A3YR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A40K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A40L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A40M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A4B3 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-FY-A4B4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-FY-A76V |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FZ-5919 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FZ-5920 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FZ-5921 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FZ-5922 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-FZ-5923 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IV] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-FZ-5924 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Malignant melanoma, NOS] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-FZ-5926 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage III] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-G2-AA3D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage IV] |
[chest, urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G3-A25W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Hepatocellular carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I, Stage IIIB] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G3-A3CG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage I, Stage IIB] |
[liver] |
[Ablation or Embolization, NOS, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-G3-A6UC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage IIIB] |
[liver] |
[Ablation or Embolization, NOS, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6293 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6294 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6295 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage II] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6297 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6298 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6299 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6302 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6303 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6304 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6306 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6307 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6309 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6310 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6311 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6314 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage IV] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Stereotactic/Gamma Knife/SRS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6315 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6317 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6320 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage III] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6321 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage III] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6322 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6323 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6586 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6588 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6625 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Malignant melanoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6626 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G4-6627 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G4-6628 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G5-6233 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G5-6235 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G5-6572 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[rectum] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G5-6641 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[rectum] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G6-A5PC |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-G6-A8L6 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G6-A8L7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, nodular, Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G6-A8L8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-6789 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Immunotherapy (Including Vaccines)] |
| TCGA.TCGA-G7-6790 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-6792 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-6793 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[kidney] |
[Chemotherapy] |
| TCGA.TCGA-G7-6795 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-G7-6796 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-6797 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[] |
| TCGA.TCGA-G7-7501 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G7-7502 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-A4TM |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-A8LB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-A8LC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G7-A8LD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-G7-A8LE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-G9-6329 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6332 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6333 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6336 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6338 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6339 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6342 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6343 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6347 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6348 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6351 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-G9-6353 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6354 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6356 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6361 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6362 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6363 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6364 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6365 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6366 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6367 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6369 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6370 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6371 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6373 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6377 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6378 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6379 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6384 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6385 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6494 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6496 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6498 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-6499 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7509 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7510 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7519 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7521 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7522 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7523 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-7525 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-A9S0 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-A9S4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-G9-A9S7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-GC-A3BM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GC-A3RB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GC-A3YS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GE-A2C6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-6846 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[] |
| TCGA.TCGA-GL-7773 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-7966 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-GL-8500 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-A4EM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-A59R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-A59T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GL-A9DC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-A9DD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GL-A9DE |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GU-A42P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IA, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GU-A763 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIA, Stage III] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GV-A3QF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-GV-A3QG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS, Transitional cell papillomas and carcinomas] |
[male] |
[Stage IIB, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GV-A3QK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage 0, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-GV-A6ZA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-H2-A26U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-H2-A2K9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-H2-A3RI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Surgery, NOS] |
| TCGA.TCGA-H2-A421 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-H2-A422 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-H5-A2HR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-H6-8124 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-H6-A45N |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Malignant melanoma, NOS] |
[female] |
[Stage IIB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-H8-A6C1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-H9-7775 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-H9-A6BX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-H9-A6BY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7075 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7077 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7078 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7079 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7080 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7081 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-HC-7209 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7210 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7211 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7212 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Radiation, External Beam] |
| TCGA.TCGA-HC-7213 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7230 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7231 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7232 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7233 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HC-7736 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7737 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7738 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7740 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7741 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7742 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7744 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-HC-7745 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7747 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-HC-7748 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7749 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7750 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7752 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7817 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-HC-7818 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7819 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7820 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-7821 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8212 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8213 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8216 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8256 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8257 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8258 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8259 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8260 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8261 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8262 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8264 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-8265 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-HC-8266 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A48F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-HC-A4ZV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A631 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A632 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6AL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6AN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6AO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6AP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6AQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basaloid squamous cell carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HC-A6AS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6HX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A6HY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A76W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HC-A76X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A8CY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A8D0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A8D1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A9TE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HC-A9TH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-7128 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[] |
| TCGA.TCGA-HE-7129 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-7130 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-A5NF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HE-A5NH |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-A5NI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-A5NJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-A5NK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HE-A5NL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HF-7131 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB, Stage IIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HF-7132 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-HF-7133 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-HF-7134 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HF-7136 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HF-A5NB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-HI-7168 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HI-7169 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HI-7170 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HI-7171 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-HJ-7597 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[female] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HQ-A2OF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HQ-A5ND |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-8238 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8243 |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-8244 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8245 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8249 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8602 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8604 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-8608 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-8610 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4G2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4G3 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4G6 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4G8 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4G9 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GC |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GD |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-A4GF |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GH |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GJ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-A4GN |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-A4GP |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GQ |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GT |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GU |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GX |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4GY |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H0 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H3 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HU-A4H4 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H5 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H6 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4H8 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4HB |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HU-A4HD |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HV-A5A3 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HV-A5A4 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-HV-A5A5 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HV-A5A6 |
Cancer-Related Death |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HV-A7OL |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HV-A7OP |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HV-AA8V |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HV-AA8X |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HZ-7289 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-7918 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-7919 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-7920 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-7922 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-7923 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-7924 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-7925 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-7926 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-8001 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage III] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-8002 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-8003 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-8005 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-8315 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-8317 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-8519 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-8636 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IV] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HZ-8637 |
Non-Cancer Related Death |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-8638 |
Surgical Complication |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-A49G |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-A49H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-A49I |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-HZ-A4BH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-A4BK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-A77O |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-A77P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-HZ-A77Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-A8P0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-HZ-A8P1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-HZ-A9TJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Total Pancreatectomy] |
| TCGA.TCGA-IA-A40U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A40X |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A40Y |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A83S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A83T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A83V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IA-A83W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-7644 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IV] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7645 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7646 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7647 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7649 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7651 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7652 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Radiation Therapy, NOS] |
| TCGA.TCGA-IB-7654 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7885 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-7886 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-7887 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-7888 |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7889 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7890 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-7891 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-7893 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-7897 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-8126 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage III] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-8127 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A5SO |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A5SP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A5SQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A5SS |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Infiltrating ductular carcinoma, Squamous cell carcinoma in situ, NOS] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-A5ST |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-A6UF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A6UG |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-A7LX |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-A7M4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IB-AAUM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-AAUN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-AAUO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-AAUP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-AAUQ |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IB-AAUR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IB-AAUS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-AAUT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-AAUU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-AAUV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-IB-AAUW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-IC-A6RE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IG-A4QS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IG-A7DP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[esophagus] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IM-A3EB |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-IM-A3ED |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IM-A420 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-7806 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-7808 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-8462 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IN-8663 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage I] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RO |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IN-A6RR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A6RS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A7NR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A7NT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-A7NU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-AB1V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IN-AB1X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-IP-7968 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[] |
| TCGA.TCGA-IR-A3LA |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-IR-A3LB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IR-A3LF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Brachytherapy, High Dose, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal] |
| TCGA.TCGA-IR-A3LI |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[uterine cervix] |
[Chemotherapy, Hysterectomy, NOS, Radiation, External Beam] |
| TCGA.TCGA-IZ-8195 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IZ-8196 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-IZ-A6M8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Papillary squamous cell carcinoma] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-IZ-A6M9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J2-8192 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-J2-8194 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-J2-A4AD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J2-A4AE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J2-A4AG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-8198 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-8200 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A67T |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A6G1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-J4-A6G3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-J4-A6M7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83I |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-A83N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-AATV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-AATZ |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J4-AAU2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J7-6720 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J7-8537 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-J7-A8I2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-J8-A3NZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Lobular carcinoma in situ, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS] |
| TCGA.TCGA-J8-A3O1 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3O2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3YD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3YE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3YF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3YG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A3YH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-J8-A42S |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J8-A4HW |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-J8-A4HY |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A52B |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A52C |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A52D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A52E |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A8CK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A8CL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A8CM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-J9-A8CN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Clear cell adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-J9-A8CP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-JU-AAVI |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIC1] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-JW-A69B |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Brachytherapy, Low Dose, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-JX-A3Q8 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-JY-A6F8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-JY-A6FB |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-JY-A6FH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-JY-A938 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-JY-A939 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-JY-A93C |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-JY-A93D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[esophagus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-JY-A93E |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-K4-A3WU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-K4-A4AB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-K4-A4AC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-K4-A54R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IIC] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-K6-A3WQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IVB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-KB-A6F5 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KB-A6F7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-KB-A93G |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KB-A93H |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KB-A93J |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-KC-A4BL |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A4BN |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A4BO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A4BR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A4BV |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A7F3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A7F5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A7F6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A7FA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary transitional cell carcinoma] |
[male] |
[Stage 0a] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KC-A7FD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KC-A7FE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KJ-A3U4 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS, Infiltrating ductular carcinoma, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-KK-A59V |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A59X |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A59Y |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-KK-A59Z |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A5A1 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6DY |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E0 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-KK-A6E1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-KK-A6E2 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E3 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E4 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E5 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E7 |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A6E8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KK-A7AQ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AV |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AW |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AY |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7AZ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7B0 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7B1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7B2 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A7B3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KK-A7B4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KK-A8I4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8I5 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8I6 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8I7 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-KK-A8I8 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-KK-A8I9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-KK-A8IA |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IB |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KK-A8IC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8ID |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IF |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8II |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-KK-A8IJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IK |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KK-A8IM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KL-8328 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Renal cell carcinoma, chromophobe type] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KM-A7Q7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, chromophobe type] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KO-8411 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Renal cell carcinoma, chromophobe type] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KP-A3VZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basaloid squamous cell carcinoma, Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IV] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-KP-A3W0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-KP-A3W1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-KP-A3W3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive, Surgery, NOS] |
| TCGA.TCGA-KP-A3W4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-KQ-A41N |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KQ-A41P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KQ-A41Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage 0a, Stage IIA, Stage III] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KR-A7K7 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[female] |
[Stage II] |
[liver] |
[Ablation or Embolization, NOS, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-KS-A41F |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A41J |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, Radiation, Systemic] |
| TCGA.TCGA-KS-A4I1 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4I3 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4I5 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4I7 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4I9 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4IB |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KS-A4IC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-KV-A6GD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KV-A6GE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-KV-A74V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L1-A7W4 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-L4-A4E5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L4-A4E6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A43C |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Carcinoma, NOS, Cystic, mucinous and serous neoplasms, Mucinous adenocarcinoma] |
[male] |
[Stage III] |
[esophagus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A43E |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A43I |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS, Plasma cell myeloma] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A43M |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A4OE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A4OF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A4OH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OI |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Basal cell carcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A4OJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4ON |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OO |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OQ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A4OR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A4OX |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A88T |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A88V |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A88Y |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A891 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A893 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage I] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NE |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, NOS, Adenoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NF |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IVA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NI |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NJ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NN |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage III] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NS |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-L5-A8NV |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L5-A8NW |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L6-A4EP |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-L6-A4EQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic] |
| TCGA.TCGA-L7-A6VZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[esophagus] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-L9-A443 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L9-A444 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA, Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L9-A50W |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L9-A5IP |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L9-A743 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-L9-A7SV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-L9-A8F4 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation, Internal] |
| TCGA.TCGA-LB-A7SX |
Non-Cancer Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-LB-A8F3 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-LB-A9Q5 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-LD-A74U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating duct carcinoma, NOS, Infiltrating lobular mixed with other types of carcinoma, Neoplasm, malignant] |
[female] |
[Stage IIIC] |
[breast] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-LI-A9QH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Lepidic adenocarcinoma, Sarcoma, NOS, Undifferentiated sarcoma] |
[female] |
[] |
[] |
[] |
| TCGA.TCGA-LK-A4O4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Epithelioid mesothelioma, malignant, Mesothelioma, malignant] |
[male] |
[Stage III] |
[mesothelium] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Pleurodesis, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-LP-A5U2 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IIIB] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-LP-A7HU |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A71Y |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A71Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A720 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A721 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A722 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M7-A723 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-M7-A724 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-M7-A725 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-M8-A5N4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-M9-A5M8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MG-AAMC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A55W |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A55Z |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A560 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A561 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A562 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A854 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A855 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Combined small cell carcinoma, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II, Stage IV] |
[kidney] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MH-A856 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MH-A857 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Renal cell carcinoma, chromophobe type] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MK-A4N6 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, Systemic] |
| TCGA.TCGA-MK-A4N7 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, Systemic] |
| TCGA.TCGA-MK-A4N9 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[thyroid gland] |
[Hormone Therapy, I-131 Radiation Therapy, Radiation, External Beam, Radiation, Systemic] |
| TCGA.TCGA-MK-A84Z |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Papillary carcinoma, follicular variant] |
[male] |
[Stage III] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, Systemic, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MM-A563 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MM-A564 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MM-A84U |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Papillary microcarcinoma, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MN-A4N1 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage II, Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MN-A4N4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MN-A4N5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4SV |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4SW |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4SY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4T2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4T4 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4T6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4T7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4T8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4T9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary transitional cell carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Squamous cell carcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[chest, lung] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4TI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A4TJ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MP-A4TK |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MP-A5C7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MX-A5UG |
Cancer-Related Death |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MX-A5UJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-MX-A663 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-MX-A666 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-N6-A4VD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinosarcoma, NOS, Mullerian mixed tumor] |
[female] |
[Stage IIIA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Surgery, Open] |
| TCGA.TCGA-NC-A5HM |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Lepidic adenocarcinoma, Squamous cell carcinoma, NOS] |
[male] |
[Stage IB] |
[lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-NH-A50T |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NH-A50U |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[male] |
[Stage IVA] |
[colon] |
[Ancillary Treatment, Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-NH-A50V |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-NH-A5IV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NH-A6GA |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-NH-A6GB |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Ancillary Treatment, Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| TCGA.TCGA-NH-A6GC |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IVB] |
[colon] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| TCGA.TCGA-NH-A8F7 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIA, Stage IVB] |
[colon] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-NH-A8F8 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[colon] |
[Chemotherapy, Immunotherapy (Including Vaccines), Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A4YF |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A4YG |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A4YI |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A4YP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[male] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A4YQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A55A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Acinar cell carcinoma, Adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A55O |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A55R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Solid carcinoma, NOS] |
[male] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-NJ-A7XG |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[chest, lung] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-O1-A52J |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-O9-A75Z |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-OE-A75W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-OL-A66H |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating duct carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB] |
[breast] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, NOS] |
| TCGA.TCGA-OR-A5KP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adrenal cortical carcinoma, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[adrenal cortex, adrenal gland] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-OR-A5LB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adrenal cortical carcinoma, Lepidic adenocarcinoma] |
[male] |
[Stage IV] |
[adrenal cortex, adrenal gland] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-P4-A5E6 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-A5E7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-A5E8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-P4-A5EA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-P4-A5EB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-A5ED |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-AAVK |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-AAVL |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-P4-AAVM |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-P4-AAVO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-PG-A5BC |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-PG-A6IB |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-PG-A7D5 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-PG-A914 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Open] |
| TCGA.TCGA-PG-A915 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-PG-A916 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-PG-A917 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IA] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-PJ-A5Z8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage I, Stage IV] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-PJ-A5Z9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-PJ-A8JU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Infiltrating ductular carcinoma, Papillary adenocarcinoma, NOS] |
[female] |
[Stage I, Stage IA] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-PK-A5HB |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adrenal cortical carcinoma, Clear cell adenocarcinoma, NOS] |
[male] |
[] |
[adrenal cortex, adrenal gland] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-PZ-A5RE |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-Q1-A5R1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Q1-A6DV |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Q1-A73P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Q1-A73R |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Q2-A5QZ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-Q3-A5QY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-Q3-AA2A |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-Q9-A6FW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QD-A8IV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Neoplasm, malignant, Papillary adenocarcinoma, NOS] |
[female] |
[Stage IVA] |
[thyroid gland] |
[I-131 Radiation Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-QF-A5YS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-QF-A5YT |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage II] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation, Internal, Surgery, Minimally Invasive] |
| TCGA.TCGA-QG-A5YV |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-QG-A5YW |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIIC] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-QG-A5YX |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[female] |
[Stage IIA] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-QG-A5Z1 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-QG-A5Z2 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[CDS, GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS, Adenoma, NOS] |
[male] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QL-A97D |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage I] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QS-A5YQ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Surgery, Minimally Invasive] |
| TCGA.TCGA-QS-A5YR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-QS-A744 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-QS-A8F1 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Serous carcinoma, NOS] |
[female] |
[Stage IIIA] |
[uterus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Minimally Invasive] |
| TCGA.TCGA-QU-A6IL |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QU-A6IM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hodgkin lymphoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-QU-A6IN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QU-A6IO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-QU-A6IP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R3-A69X |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R5-A7O7 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A7ZE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A7ZF |
Cancer-Related Death |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A7ZI |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A7ZR |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage III] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A804 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R5-A805 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-R6-A6DN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6DQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6KZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6L4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6L6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6XG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6XQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IVB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6Y0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IVA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A6Y2 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A8W5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IVA] |
[esophagus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A8W8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-R6-A8WC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[] |
| TCGA.TCGA-R6-A8WG |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RB-A7B8 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Adenocarcinoma with mixed subtypes] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-RB-AA9M |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A7BS |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A7BT |
Cancer-Related Death |
Non-Hispanic |
Native Hawaiian or Other Pacific Islander |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A7BW |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Chemotherapy, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-RD-A7C1 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A8MV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8MW |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A8N0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8N1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8N2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-RD-A8N4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8N5 |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8N6 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RD-A8N9 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-RD-A8NB |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RE-A7BO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[female] |
[Stage IIB] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-RL-AAAS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-RU-A8FL |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[colon] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RW-A68F |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Glomus tumor, NOS, Papillary adenocarcinoma, NOS, Pheochromocytoma, NOS] |
[female] |
[] |
[adrenal gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-RW-A68G |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Pheochromocytoma, NOS] |
[male] |
[] |
[adrenal gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-S2-AA1A |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Lepidic adenocarcinoma] |
[female] |
[Stage IA] |
[chest, lung] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-S4-A8RM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Total Pancreatectomy] |
| TCGA.TCGA-S4-A8RO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-S4-A8RP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-S5-A6DX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-S7-A7WU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Pheochromocytoma, NOS] |
[female] |
[] |
[adrenal gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-S7-A7X1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Pheochromocytoma, NOS] |
[male] |
[] |
[adrenal gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-S8-A6BV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Chemotherapy, Distal Pancreatectomy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-SJ-A6ZI |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-SJ-A6ZJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation, Internal, Surgery, Open] |
| TCGA.TCGA-SL-A6J9 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-SL-A6JA |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage IB] |
[uterus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, Open] |
| TCGA.TCGA-SS-A7HO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[colon] |
[Ancillary Treatment, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-SU-A7E7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SW-A7EA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[female] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SW-A7EB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A71R |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A71S |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A71U |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A71V |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A71W |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage 0, Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-SX-A7SL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SM |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[kidney] |
[Radiation Therapy, NOS, Targeted Molecular Therapy] |
| TCGA.TCGA-SX-A7SN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-SX-A7SP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SX-A7SU |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-SY-A9G0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IIB, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-T7-A92I |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Renal cell carcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-T9-A92H |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-TK-A8OK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-TP-A8TT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-TP-A8TV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-UB-A7MF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[male] |
[Stage II, Stage IIIA] |
[liver] |
[Ablation or Embolization, NOS, Organ Transplantation, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UC-A7PI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UN-AAZ9 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-US-A774 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-US-A776 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIA] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-US-A779 |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-US-A77E |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-US-A77G |
Surgical Complication |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-US-A77J |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-UT-A88D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Epithelioid mesothelioma, malignant, Mesothelioma, malignant] |
[male] |
[Stage I, Stage II] |
[mesothelium] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Pleurodesis, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UY-A78N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PQ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9PX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9PZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-UZ-A9Q0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-UZ-A9Q1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MF |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MG |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MJ |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8ML |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MM |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8MU |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8WL |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8WN |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8WS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8WV |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8WW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A8X3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9O5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-V1-A9O7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-V1-A9O9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OA |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OL |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OQ |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OT |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9OY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9Z7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9Z8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9Z9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9ZG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9ZI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9ZK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Signet ring cell carcinoma] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V1-A9ZR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-V5-A7RB |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-V5-A7RE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IB] |
[esophagus] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-V5-AASW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIA] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-V5-AASX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IV] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-V9-A7HT |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage II] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88I |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88M |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88N |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88O |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88Q |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A88R |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VN-A943 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A872 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A875 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A876 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A878 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A879 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87B |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87C |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Chemotherapy, Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87E |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87H |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87J |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-A87K |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-VP-AA1N |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8DL |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8DT |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8DU |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8DV |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8DZ |
Cancer-Related Death |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8E0 |
Cancer-Related Death |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8E2 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8E3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8E7 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8P2 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8P3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8P5 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8P8 |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PB |
Non-Cancer Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[female] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8PC |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PD |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PE |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PF |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PH |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PJ |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PK |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PM |
Non-Cancer Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PO |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PP |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PQ |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IV] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PS |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Basal cell carcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage I, Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A8PX |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A8PY |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A8PZ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[female] |
[Stage II] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A91A |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A91D |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A91E |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[female] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A91K |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A91N |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A91Q |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A91S |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A91U |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A91V |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A91W |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-A91X |
Non-Cancer Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A91Y |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A91Z |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A922 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A923 |
Non-Cancer Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A924 |
Cancer-Related Death |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage II] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A925 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A927 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A928 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage IV] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A92D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A94O |
Cancer-Related Death |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A94P |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-A94R |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A94T |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-A94U |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage I, Stage IIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-AA64 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-AA68 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-AA69 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIA] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-AA6A |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-AA6B |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-AA6D |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIA] |
[stomach] |
[Chemotherapy, Radiation, External Beam] |
| TCGA.TCGA-VQ-AA6F |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-AA6G |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIA] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-AA6I |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VQ-AA6J |
<NA> |
<NA> |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IIIB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VQ-AA6K |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Signet ring cell carcinoma] |
[male] |
[Stage IIIC] |
[stomach] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VR-A8EQ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Carcinoma, NOS, Tubular adenocarcinoma] |
[male] |
[Stage III] |
[esophagus] |
[Chemotherapy, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VR-AA4D |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIB] |
[esophagus] |
[Ancillary Treatment, Chemotherapy, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A8QH |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal] |
| TCGA.TCGA-VS-A952 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VS-A9UO |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal] |
| TCGA.TCGA-VS-A9UP |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A9UQ |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB] |
[uterine cervix] |
[Brachytherapy, High Dose, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A9UR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIA] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A9UT |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-VS-A9UZ |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB1] |
[uterine cervix] |
[Brachytherapy, High Dose, Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation, Internal] |
| TCGA.TCGA-VS-A9V0 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IB] |
[uterine cervix] |
[Brachytherapy, High Dose, Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation, Internal, Surgery, NOS] |
| TCGA.TCGA-VS-A9V1 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IVB] |
[uterine cervix] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A9V4 |
Cancer-Related Death |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage I, Stage IVA] |
[uterine cervix] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-VS-A9V5 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Mucinous adenocarcinoma, Neoplasm, malignant] |
[female] |
[Stage IIB] |
[uterine cervix] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation, 3D Conformal, Radiation, External Beam] |
| TCGA.TCGA-W3-A824 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage I] |
[skin of body] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WC-A87U |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS, Spindle cell melanoma, type B] |
[male] |
[Stage IIIA] |
[eye, uvea] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WE-A8ZO |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Low cumulative sun damage melanoma, Malignant melanoma, NOS] |
[female] |
[Stage IIIB] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WE-A8ZY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Malignant melanoma, NOS] |
[male] |
[Stage IIA] |
[skin of body] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-WJ-A86L |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[female] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WN-A9G9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WN-AB4C |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-WS-AB45 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Mucinous adenocarcinoma] |
[female] |
[Stage IIA] |
[colon] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-WW-A8ZI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-X4-A8KQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-X4-A8KS |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-X8-AAAR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XA-A8JR |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XD-AAUG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IV] |
[pancreas] |
[Ancillary Treatment, Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XD-AAUH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-XD-AAUI |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-XD-AAUL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma, Squamous cell carcinoma, NOS] |
[male] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-XF-A8HD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A8HE |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A8HF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A8HG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9SJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9SM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9SP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9SW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9SY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[female] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9T0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9T2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage II, Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-A9T8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAMF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAML |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary transitional cell carcinoma, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAMR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAMY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary transitional cell carcinoma, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAN2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAN3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAN7 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Chemotherapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XF-AAN8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[female] |
[Stage III] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XJ-A83F |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XJ-A83G |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XJ-A83H |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XJ-A9DI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-XJ-A9DK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XJ-A9DQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XJ-A9DX |
<NA> |
Non-Hispanic |
American Indian or Alaska Native |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAIR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAIV |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAIW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAJ3 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XK-AAJA |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAJP |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAJR |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAJT |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAJU |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XK-AAK1 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, NOS] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XM-A8RD |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Basal cell carcinoma, NOS, Papillary adenocarcinoma, NOS, Thymoma, NOS, Thymoma, type B2] |
[female] |
[] |
[thymus] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-XN-A8T3 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-XN-A8T5 |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IB] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS, Whipple] |
| TCGA.TCGA-XQ-A8TA |
Cancer-Related Death |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-XQ-A8TB |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y6-A8TL |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y6-A9XI |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A894 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A895 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-Y8-A896 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A897 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[female] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A898 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I, Stage III] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-Y8-A8RY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A8RZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-Y8-A8S0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-Y8-A8S1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[Stage I] |
[kidney] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YB-A89D |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[male] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Radiation, External Beam, Whipple] |
| TCGA.TCGA-YF-AA3M |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage I, Stage II, Stage IIB] |
[urinary bladder] |
[Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-YH-A8SY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[pancreas] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Whipple] |
| TCGA.TCGA-YJ-A8SW |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Mucinous adenocarcinoma, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8HJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A8HK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A8HL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A8HM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A8HO |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8S8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8S9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SA |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-YL-A8SB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-YL-A8SC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SF |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SH |
Non-Cancer Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SK |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A8SL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SO |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SP |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SQ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A8SR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A9WH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A9WI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A9WJ |
Cancer-Related Death |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A9WK |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A9WL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-YL-A9WX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YL-A9WY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-YY-A8LH |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIB] |
[pancreas] |
[Chemotherapy, Distal Pancreatectomy, Radiation, External Beam] |
| TCGA.TCGA-Z5-AAPL |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Infiltrating ductular carcinoma] |
[female] |
[Stage IIA] |
[pancreas] |
[Chemotherapy, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZA-A8F6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, intestinal type, Adenocarcinoma, NOS] |
[male] |
[Stage IB] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZB-A96K |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Thymoma, NOS, Thymoma, type AB] |
[male] |
[] |
[thymus] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZF-A9RC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage III] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZF-AA53 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma in situ, NOS, Carcinoma, NOS, Papillary transitional cell carcinoma, non-invasive, Transitional cell carcinoma, NOS] |
[male] |
[Stage II] |
[urinary bladder] |
[Chemotherapy, Immunotherapy (Including Vaccines), Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZF-AA5P |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS, Transitional cell carcinoma, NOS] |
[male] |
[Stage IV] |
[urinary bladder] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZG-A8QW |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A8QX |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A8QY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A8QZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9KY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L0 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9L2 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L5 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L6 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9L9 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9LB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9LM |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9LN |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9LS |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9LU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9LY |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9LZ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9M4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9MC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation, External Beam] |
| TCGA.TCGA-ZG-A9N3 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Hormone Therapy, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9ND |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZG-A9NI |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[male] |
[] |
[prostate gland] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZH-A8Y1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Cholangiocarcinoma, Clear cell adenocarcinoma, NOS] |
[female] |
[Stage III, Stage IVA] |
[bile duct] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZH-A8Y8 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Cholangiocarcinoma] |
[male] |
[Stage I] |
[bile duct] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZJ-AAX4 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant, Squamous cell carcinoma, large cell, nonkeratinizing, NOS] |
[female] |
[Stage II] |
[uterine cervix] |
[Hysterectomy, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZJ-AAXB |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage IB2] |
[uterine cervix] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZP-A9D1 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Clear cell adenocarcinoma, NOS, Hepatocellular carcinoma, NOS] |
[female] |
[Stage I] |
[liver] |
[Ablation or Embolization, NOS, Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| TCGA.TCGA-ZQ-A9CR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Tubular adenocarcinoma] |
[female] |
[Stage IIIC] |
[stomach] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS] |
| TCGA.TCGA-ZR-A9CJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC, IDC] |
[Adenocarcinoma, NOS, Carcinoma, NOS] |
[male] |
[Stage IIIC] |
[esophagus] |
[Pharmaceutical Therapy, NOS, Radiation Therapy, NOS, Surgery, NOS] |
| VAREPOP.AP-6H6G |
<NA> |
Non-Hispanic |
White |
human |
1959 |
<NA> |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Large cell carcinoma, NOS] |
[male] |
[] |
[chest] |
[Chemotherapy] |
| VAREPOP.AP-6M60 |
<NA> |
Non-Hispanic |
<NA> |
human |
1944 |
2016 |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[female] |
[] |
[chest] |
[Chemotherapy, Surgery, NOS] |
| VAREPOP.AP-95DK |
<NA> |
Non-Hispanic |
White |
human |
1948 |
<NA> |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[male] |
[] |
[abdomen, chest] |
[Chemotherapy] |
| VAREPOP.AP-97PG |
<NA> |
Non-Hispanic |
<NA> |
human |
1942 |
<NA> |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[male] |
[] |
[chest, pelvic region of trunk, trunk] |
[Surgery, NOS] |
| VAREPOP.AP-9GTR |
<NA> |
Non-Hispanic |
<NA> |
human |
1956 |
2016 |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[male] |
[] |
[chest] |
[Chemotherapy] |
| VAREPOP.AP-CL9I |
<NA> |
Non-Hispanic |
<NA> |
human |
1944 |
<NA> |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[male] |
[] |
[chest] |
[Surgery, NOS] |
| VAREPOP.AP-DRVN |
<NA> |
Non-Hispanic |
White |
human |
1950 |
<NA> |
[GDC, IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma, Squamous cell carcinoma, NOS] |
[male] |
[] |
[abdomen, trunk] |
[Chemotherapy] |
| WCDT.DTB-003 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-005 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-008 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-009 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-011 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-018 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-019 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-020 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-021 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-022 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-023 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-024 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-034 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-035 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-036 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-037 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-040 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-042 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-053 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-055 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-059 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-060 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-061 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-063 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-064 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-067 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-069 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-071 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-074 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-077 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-080 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-083 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-085 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-089 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-090 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-091 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-092 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-094 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-097 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-098 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-100 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-101 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-102 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-104 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-111 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-112 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-119 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-121 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-124 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-126 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-127 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-128 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-129 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-132 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-135 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-137 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-138 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-140 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-141 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-143 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-146 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-149 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-151 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-156 |
<NA> |
Non-Hispanic |
Black or African American |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-159 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-165 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-167 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-170 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-172 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-173 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-175 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-176 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-183 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-186 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-187 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-188 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-190 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-193 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-194 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-201 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-202 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-204 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, liver] |
[] |
| WCDT.DTB-205 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-206 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-210 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-213 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-214 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-216 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-220 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-222 |
<NA> |
Non-Hispanic |
<NA> |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood] |
[] |
| WCDT.DTB-223 |
<NA> |
<NA> |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-232 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-234 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-251 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-252 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-255 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-258 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, lymph node] |
[] |
| WCDT.DTB-260 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-261 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-265 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| WCDT.DTB-266 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[GDC] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[Stage IV] |
[blood, bone tissue] |
[] |
| Academia Sinica LUAD-100.P002 |
<NA> |
<NA> |
<NA> |
human |
1943 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P006 |
<NA> |
<NA> |
<NA> |
human |
1970 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P007 |
<NA> |
<NA> |
<NA> |
human |
1949 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIA] |
[] |
[] |
| Academia Sinica LUAD-100.P008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[] |
[] |
| Academia Sinica LUAD-100.P009 |
<NA> |
<NA> |
<NA> |
human |
1963 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[] |
[IIA] |
[] |
[] |
| Academia Sinica LUAD-100.P010 |
<NA> |
<NA> |
<NA> |
human |
1960 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P011 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P012 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P013 |
<NA> |
<NA> |
<NA> |
human |
1972 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P015 |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P016 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P017 |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P018 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P019 |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P020 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Academia Sinica LUAD-100.P021 |
<NA> |
<NA> |
<NA> |
human |
1931 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P022 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P023 |
<NA> |
<NA> |
<NA> |
human |
1960 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P024 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P025 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P026 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P027 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P028 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P029 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P030 |
<NA> |
<NA> |
<NA> |
human |
1967 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P031 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P032 |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P033 |
<NA> |
<NA> |
<NA> |
human |
1965 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P034 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P036 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P037 |
<NA> |
<NA> |
<NA> |
human |
1955 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P038 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P039 |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P040 |
<NA> |
<NA> |
<NA> |
human |
1969 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P042 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P043 |
<NA> |
<NA> |
<NA> |
human |
1938 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P044 |
<NA> |
<NA> |
<NA> |
human |
1944 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P045 |
<NA> |
<NA> |
<NA> |
human |
1940 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P048 |
<NA> |
<NA> |
<NA> |
human |
1962 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P049 |
<NA> |
<NA> |
<NA> |
human |
1964 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P050 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P051 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P052 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P053 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P054 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P055 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P056 |
<NA> |
<NA> |
<NA> |
human |
1937 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P057 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P058 |
<NA> |
<NA> |
<NA> |
human |
1931 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P059 |
<NA> |
<NA> |
<NA> |
human |
1959 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P060 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P061 |
<NA> |
<NA> |
<NA> |
human |
1932 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P062 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P063 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P064 |
<NA> |
<NA> |
<NA> |
human |
1945 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P066 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P067 |
<NA> |
<NA> |
<NA> |
human |
1975 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P068 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P069 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P070 |
<NA> |
<NA> |
<NA> |
human |
1932 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P071 |
<NA> |
<NA> |
<NA> |
human |
1948 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P072 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P073 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P075 |
<NA> |
<NA> |
<NA> |
human |
1969 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P076 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P077 |
<NA> |
<NA> |
<NA> |
human |
1972 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Academia Sinica LUAD-100.P078 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P079 |
<NA> |
<NA> |
<NA> |
human |
1958 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P080 |
<NA> |
<NA> |
<NA> |
human |
1941 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P081 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Academia Sinica LUAD-100.P082 |
<NA> |
<NA> |
<NA> |
human |
1947 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P083 |
<NA> |
<NA> |
<NA> |
human |
1964 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P085 |
<NA> |
<NA> |
<NA> |
human |
1953 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P086 |
<NA> |
<NA> |
<NA> |
human |
1946 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P088 |
<NA> |
<NA> |
<NA> |
human |
1954 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P089 |
<NA> |
<NA> |
<NA> |
human |
1942 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P090 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P091 |
<NA> |
<NA> |
<NA> |
human |
1952 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P092 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P093 |
<NA> |
<NA> |
<NA> |
human |
1943 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IV] |
[] |
[] |
| Academia Sinica LUAD-100.P094 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P095 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IIIA] |
[] |
[] |
| Academia Sinica LUAD-100.P097 |
<NA> |
<NA> |
<NA> |
human |
1950 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P098 |
<NA> |
<NA> |
<NA> |
human |
1970 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Academia Sinica LUAD-100.P099 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P100 |
<NA> |
<NA> |
<NA> |
human |
1940 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P101 |
<NA> |
<NA> |
<NA> |
human |
1961 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IV] |
[] |
[] |
| Academia Sinica LUAD-100.P102 |
<NA> |
<NA> |
<NA> |
human |
1966 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIIB] |
[] |
[] |
| Academia Sinica LUAD-100.P103 |
<NA> |
<NA> |
<NA> |
human |
1956 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[IV] |
[] |
[] |
| Academia Sinica LUAD-100.P104 |
<NA> |
<NA> |
<NA> |
human |
1964 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IV] |
[] |
[] |
| Academia Sinica LUAD-100.P109 |
<NA> |
<NA> |
<NA> |
human |
1973 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P110 |
<NA> |
<NA> |
<NA> |
human |
1968 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IA] |
[] |
[] |
| Academia Sinica LUAD-100.P111 |
<NA> |
<NA> |
<NA> |
human |
1951 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P112 |
<NA> |
<NA> |
<NA> |
human |
1957 |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Academia Sinica LUAD-100.P113 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P114 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P115 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3B] |
[] |
[] |
| Academia Sinica LUAD-100.P117 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P118 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P119 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P121 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P122 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P123 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P125 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P126 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2B] |
[] |
[] |
| Academia Sinica LUAD-100.P127 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P128 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P129 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P130 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P131 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P132 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P133 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P135 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P137 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P138 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P139 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P140 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P141 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P142 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P143 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P144 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3B] |
[] |
[] |
| Academia Sinica LUAD-100.P145 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Mucinous adenocarcinoma] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P146 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P147 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P148 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P149 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2B] |
[] |
[] |
| Academia Sinica LUAD-100.P152 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P153 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P154 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P155 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P156 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P158 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P159 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P160 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P161 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P163 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P164 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P165 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P168 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P169 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P170 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P171 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P172 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P173 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P174 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P175 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P176 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P177 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P178 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P179 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P180 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage4] |
[] |
[] |
| Academia Sinica LUAD-100.P181 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P182 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P183 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P184 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P186 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P187 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P188 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P189 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P190 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P191 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P192 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P193 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P194 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P195 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P196 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P197 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage2B] |
[] |
[] |
| Academia Sinica LUAD-100.P200 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P201 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P202 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P204 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P205 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P207 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P208 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage2B] |
[] |
[] |
| Academia Sinica LUAD-100.P209 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P210 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P211 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Mucinous adenocarcinoma] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P212 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P213 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P215 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P216 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P217 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P218 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P219 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P220 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P221 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P223 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P224 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P225 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage3A] |
[] |
[] |
| Academia Sinica LUAD-100.P226 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P229 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P230 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage2A] |
[] |
[] |
| Academia Sinica LUAD-100.P231 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1B] |
[] |
[] |
| Academia Sinica LUAD-100.P232 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[Stage1A] |
[] |
[] |
| Academia Sinica LUAD-100.P235 |
<NA> |
Non-Hispanic |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[Stage3B] |
[] |
[] |
| CPTAC-2.05CO004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC-2.13CO001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IIIB] |
[colon] |
[] |
| CPTAC-2.14CO001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[female] |
[Stage III] |
[colon] |
[] |
| CPTAC-2.20CO006 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[IDC, PDC] |
[Adenocarcinoma, NOS, Neoplasm, uncertain whether benign or malignant] |
[male] |
[Stage IVA] |
[colon] |
[] |
| CPTAC3 Discovery and Confirmatory.C3L-00084 |
<NA> |
Non-Hispanic |
White |
human |
1942 |
<NA> |
[CDS, PDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[Stage I] |
[uterus] |
[] |
| CPTAC3 Discovery and Confirmatory.C3L-01284 |
<NA> |
Non-Hispanic |
Asian |
human |
1967 |
<NA> |
[CDS, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage I] |
[uterus] |
[] |
| CPTAC3 Discovery and Confirmatory.C3N-01001 |
<NA> |
<NA> |
White |
human |
1944 |
<NA> |
[CDS, IDC, PDC] |
[Endometrioid adenocarcinoma, NOS, Neoplasm, malignant] |
[female] |
[Stage II] |
[abdomen, pelvic region of trunk, uterus] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000001 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Lepidic adenocarcinoma] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000002 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000003 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000004 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000005 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000007 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000008 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000009 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| Georgetown Lung Cancer Proteomics Study.ICBI-000010 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[lung] |
[] |
| Human Early-Onset Gastric Cancer - Korea University.33 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| Human Early-Onset Gastric Cancer - Korea University.54 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[] |
[] |
| Human Early-Onset Gastric Cancer - Korea University.61 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[] |
[] |
| Korea University - Cervical cancer.CCA120 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA122 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA124 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA125 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Korea University - Cervical cancer.CCA128 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA130 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IVB] |
[] |
[] |
| Korea University - Cervical cancer.CCA131 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA133 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA134 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA186 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA188 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Korea University - Cervical cancer.CCA189 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA226 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA227 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIA] |
[] |
[] |
| Korea University - Cervical cancer.CCA228 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA229 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA230 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA232 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA234 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IB] |
[] |
[] |
| Korea University - Cervical cancer.CCA237 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IVB] |
[] |
[] |
| Korea University - Cervical cancer.CCA243 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IIB] |
[] |
[] |
| Korea University - Cervical cancer.CCA251 |
<NA> |
<NA> |
Asian |
human |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[IVB] |
[] |
[] |
| National Cancer Center Korea - iCC.P001 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P002 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P003 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P004 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P005 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P006 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P007 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P008 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P009 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P010 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P011 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P012 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P013 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P014 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P015 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P016 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P017 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P018 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Mucin-producing adenocarcinoma] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P019 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P020 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P021 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P022 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P023 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P024 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P025 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P026 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P027 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P028 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P029 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P030 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P031 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P032 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P034 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P035 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P036 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P037 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P039 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P040 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P041 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P042 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P043 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P044 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P045 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P046 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P047 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P048 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P049 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P050 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P051 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P052 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P053 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P054 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P055 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P056 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P057 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P058 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P059 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P060 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P061 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P062 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P063 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P064 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P065 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P066 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P067 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P068 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P069 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P070 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P071 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P072 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P073 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P074 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P075 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P076 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P077 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P078 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P079 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P081 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P082 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P083 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P084 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P085 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P086 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P087 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P088 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P089 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P090 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P091 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P092 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P093 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P094 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P095 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P096 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P097 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P098 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P099 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P100 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P101 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.P102 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.T1 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.T27 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Mucin-producing adenocarcinoma] |
[female] |
[] |
[] |
[] |
| National Cancer Center Korea - iCC.T32 |
<NA> |
Non-Hispanic |
Asian |
<NA> |
<NA> |
<NA> |
[PDC] |
[Trabecular adenocarcinoma] |
[male] |
[] |
[] |
[] |
| PJ25730263.CA25730263-1 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[pT3a] |
[kidney] |
[] |
| PJ25730263.CA25730263-2 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[pT4] |
[kidney] |
[] |
| PJ25730263.CA25730263-3 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[pT1] |
[kidney] |
[] |
| PJ25730263.CA25730263-4 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[pT1a] |
[kidney] |
[] |
| PJ25730263.CA25730263-6 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[pT3a] |
[kidney] |
[] |
| PJ25730263.CA25730263-7 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[pT3a] |
[kidney] |
[] |
| PJ25730263.CA25730263-8 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Clear cell adenocarcinoma, NOS] |
[male] |
[pT3a] |
[kidney] |
[] |
| PJ25730263.CA25730263-9 |
<NA> |
<NA> |
<NA> |
human |
<NA> |
<NA> |
[PDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[pT1b] |
[kidney] |
[] |
| CCDI.PBBPUJ |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS] |
[Papillary adenocarcinoma, NOS] |
[female] |
[] |
[blood] |
[] |
| CCDI.PBBRUG |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[] |
[] |
| CCDI.PBBSJU |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[blood] |
[] |
| CCDI.PBBVZV |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[blood] |
[] |
| CCDI.PBBWNR |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, metastatic, NOS] |
[female] |
[] |
[blood] |
[] |
| CCDI.PBBXMR |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[blood] |
[] |
| CCDI.PBBYCC |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma in adenomatous polyposis coli] |
[male] |
[] |
[blood, sigmoid colon] |
[] |
| CCDI.PBBYIK |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, metastatic, NOS] |
[male] |
[] |
[blood] |
[] |
| CCDI.PBCABN |
<NA> |
Hispanic or Latino |
<NA> |
human |
<NA> |
<NA> |
[CDS, IDC] |
[Endometrioid adenocarcinoma, NOS] |
[female] |
[] |
[blood, ovary] |
[] |
| CCDI.PBCBKF |
<NA> |
Hispanic or Latino |
White |
human |
<NA> |
<NA> |
[CDS, IDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[blood, vagina] |
[] |
| CCDI.PBCCBJ |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS, IDC] |
[Papillary adenocarcinoma, NOS] |
[male] |
[] |
[blood, thyroid gland] |
[] |
| CCDI.TB-000132 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[blood, liver] |
[] |
| CCDI.TB-000186 |
<NA> |
Non-Hispanic |
White |
human |
<NA> |
<NA> |
[CDS] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[buccal mucosa, kidney] |
[] |
| HTAN.HTA7_920 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, rectum] |
[] |
| HTAN.HTA7_922 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, transverse colon] |
[] |
| HTAN.HTA7_925 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, sigmoid colon] |
[] |
| HTAN.HTA7_926 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, rectum] |
[] |
| HTAN.HTA7_927 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, sigmoid colon] |
[] |
| HTAN.HTA7_931 |
<NA> |
Hispanic or Latino |
<NA> |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, transverse colon] |
[] |
| HTAN.HTA7_932 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, sigmoid colon] |
[] |
| HTAN.HTA7_934 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, rectosigmoid junction] |
[] |
| HTAN.HTA7_940 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, vermiform appendix] |
[] |
| HTAN.HTA7_947 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, rectosigmoid junction] |
[] |
| HTAN.HTA7_963 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, rectum] |
[] |
| HTAN.HTA7_965 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[caecum, colon] |
[] |
| HTAN.HTA7_966 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, sigmoid colon] |
[] |
| HTAN.HTA7_972 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[colon, sigmoid colon] |
[] |
| HTAN.HTA7_982 |
<NA> |
<NA> |
Black or African American |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[caecum, colon] |
[] |
| HTAN.HTA7_989 |
<NA> |
Non-Hispanic |
White |
<NA> |
<NA> |
<NA> |
[CDS, IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[colon, transverse colon] |
[] |
| cptac_ccrcc.C3L-00609 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Clear cell adenocarcinoma, NOS] |
[female] |
[] |
[kidney] |
[] |
| cptac_luad.C3L-04370 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3L-04373 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3L-04376 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3L-04743 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3L-04744 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3L-04784 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-02231 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-02251 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-02671 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04166 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04171 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04297 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04330 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04616 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| cptac_luad.C3N-04714 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[] |
[] |
[lung] |
[] |
| pdmr_292921_168_r.292921-168-R-1404 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1405 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1406 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1407 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1408 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1409 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1410 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1411 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1412 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1413 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1414 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1415 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1416 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1417 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1418 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1419 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1420 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1421 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1422 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_292921_168_r.292921-168-R-1423 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2160 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2161 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2162 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2163 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2164 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2165 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2166 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2167 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2168 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2169 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2170 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2171 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2172 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2173 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2174 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2175 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2176 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2177 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2178 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_521955_158_r4.521955-158-R4-2179 |
<NA> |
<NA> |
<NA> |
mouse |
2021 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1565 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1566 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1567 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1568 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1569 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1570 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1571 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1572 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1573 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1574 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1575 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1576 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1577 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1578 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1579 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1580 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1581 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1582 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1583 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_833975_119_r.833975-119-R-1584 |
<NA> |
<NA> |
<NA> |
mouse |
2019 |
<NA> |
[IDC] |
[Adenocarcinoma, NOS] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_997537_175_t.997537-175-T-1311 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1314 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1317 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1318 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1319 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1320 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1321 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1322 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1323 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1324 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1325 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1326 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1327 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1328 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1329 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1330 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1331 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1332 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1333 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1334 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1335 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1336 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1337 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_997537_175_t.997537-175-T-1338 |
<NA> |
<NA> |
<NA> |
mouse |
2018 |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[abdomen, colon] |
[] |
| pdmr_texture_analysis.144126-210-T-1637 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1641 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1645 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1655 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1658 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1664 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1668 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.144126-210-T-1669 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1615 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1616 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1617 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1618 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1621 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1622 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1623 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1624 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1625 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1626 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1627 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1628 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1629 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1630 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1631 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1632 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.146476-266-R-1633 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1178 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1179 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1181 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1182 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1185 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1188 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1189 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1191 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1192 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.165739-295-R-1195 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1845 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1846 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1847 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1848 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1849 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1850 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1851 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1852 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1853 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1854 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1855 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1856 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1857 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1858 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1859 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1860 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1861 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1862 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1863 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-121-T-1864 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1238 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1241 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1242 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1243 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1244 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1246 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1247 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1250 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1254 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1257 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1259 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1260 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1261 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1262 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.172845-142-T-1265 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1986 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1987 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1991 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1992 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1994 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1995 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1998 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-1999 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-2003 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.287954-098-R-2004 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.466636-57-R-373 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.466636-57-R-444 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.466636-57-R-446 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.466636-57-R-453 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.466636-57-R-463 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female, male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2162 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2163 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2165 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2167 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2169 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2171 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2173 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2175 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2177 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R4-2179 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-516 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-594 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-595 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-597 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-611 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-613 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.521955-158-R6-614 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1536 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1541 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1542 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1544 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1545 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1546 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1547 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1548 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.625472-104-R-1550 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2037 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2038 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2039 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2043 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2044 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2048 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2051 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.695669-166-R-2054 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1953 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1955 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1959 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1970 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1977 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1978 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.698357-238-R-1980 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2005 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2007 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2008 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2010 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2011 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2012 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2017 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.765638-272-R-2023 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.779769-127-R-1675 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.779769-127-R-1678 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.779769-127-R-1685 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.779769-127-R-1691 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.779769-127-R-1693 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1567 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1568 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1570 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1572 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1575 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1576 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1577 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1579 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1580 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1582 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1583 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.833975-119-R-1584 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2305 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2315 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2318 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2320 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2321 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.894883-131-R-2322 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1319 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1321 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1322 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1326 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1327 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1330 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1331 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1334 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.997537-175-T-1338 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[male] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1711 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1712 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1714 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1715 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1716 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1718 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1723 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1724 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| pdmr_texture_analysis.BL0382-F1232-1728 |
<NA> |
<NA> |
<NA> |
mouse |
<NA> |
<NA> |
[IDC] |
[Ewing sarcoma - Peripheral PNET, Melanoma, Neuroendocrine cancer (NOS), Osteosarcoma, Anal Squamous Cell Carcinoma, Urothelial - bladder cancer (NOS), Pancreatic Adenocarcinoma, Rectal Adenocarcinoma, Colon adenocarcinoma, Lung Squamous Cell Carcinoma] |
[female] |
[] |
[abdomen] |
[] |
| tcga_coad.TCGA-AY-4070A |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[colon] |
[] |
| tcga_coad.TCGA-AY-5543A |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[colon] |
[] |
| tcga_coad.TCGA-AY-6197A |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[male] |
[] |
[colon] |
[] |
| tcga_coad.TCGA-AY-6386A |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Adenocarcinoma, intestinal type] |
[female] |
[] |
[colon] |
[] |
| varepop_apollo.AP-78LL |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdominopelvic cavity, chest] |
[] |
| varepop_apollo.AP-7DC5 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-AMT4 |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[] |
[] |
| varepop_apollo.AP-CUHF |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-DCLM |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdomen, chest, trunk] |
[] |
| varepop_apollo.AP-DKMN |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[] |
[] |
| varepop_apollo.AP-E7LJ |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdomen, appendage, lumbar region of vertebral column] |
[] |
| varepop_apollo.AP-E87U |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-EXQB |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-FMPL |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdomen, adrenal gland, chest] |
[] |
| varepop_apollo.AP-GDKX |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-GNDK |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[] |
[] |
| varepop_apollo.AP-GUEM |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-JS5B |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdominopelvic cavity] |
[] |
| varepop_apollo.AP-LCEW |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[female] |
[] |
[abdomen, chest] |
[] |
| varepop_apollo.AP-R39K |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-R45K |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[] |
[] |
| varepop_apollo.AP-RMFZ |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest, neck] |
[] |
| varepop_apollo.AP-V7RJ |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest] |
[] |
| varepop_apollo.AP-X6NA |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[] |
[] |
| varepop_apollo.AP-YGJE |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdomen, chest] |
[] |
| varepop_apollo.AP-Z5MF |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[female] |
[] |
[chest, pelvic region of trunk, trunk] |
[] |
| varepop_apollo.AP-ZPHN |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[lumbar region of vertebral column] |
[] |
| varepop_apollo.AP-ZUCQ |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[chest, trunk] |
[] |
| varepop_apollo.AP-ZVBM |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
<NA> |
[IDC] |
[Esophageal Carcinoma, Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Lung Other, Pancreatic Adenocarcinoma, Thymoma] |
[male] |
[] |
[abdomen, chest, thoracic segment of trunk] |
[] |